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ABSTRACT 
 
Aigner, Carrie J. Ph.D., Purdue University, August, 2011.  The Role of Motivation and 
Expectancy in the Placebo Effect.  Major Professor: Soren Svanum. 
 
 
 
Placebo has been found to be an important component of treatments including 
psychological and pharmacological treatment of depression, transplant surgery for 
Parkinson’s, acupuncture, smoking cessation interventions, and analgesic treatment of 
pain.  Although the placebo effect has been observed across a wide range of disciplines, 
the effect sizes vary widely and it is not well understood how placebo effects are 
produced.  The current study draws upon research in perception and motivation to 
propose a more comprehensive model of the placebo effect.  Specifically, the model 
proposes that more motivated persons pay greater attention to bodily sensations and other 
stimuli, which are then interpreted according to expectations, producing a placebo 
response.  In the current study, both motivation and outcome expectancy were 
manipulated, creating a 2x2 study design.  College students (N=152) were asked to 
evaluate a series of placebo pheromone substances (slightly scented water) and 
attention/task diligence was assessed as the amount of time spent on the rating task and 
the number of evaluations made.  The placebo response was assessed as the attractiveness 
rating of the chosen sample and the variability in ratings, with greater variability and 
higher attractiveness ratings indicating greater placebo response.  It was predicted that 
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those in the high motivation group would have greater diligence on the rating task, which 
would, in turn, lead to greater placebo response.  It was further predicted that there would 
be a main effect for expectancy on placebo response.  Consistent with hypothesized 
effects, more highly motivated students had greater placebo responses, and the 
relationship was mediated by task diligence.  Thus, as students spent greater time on the 
evaluation task, they found the scent of their chosen sample to be more pleasing and 
perceived greater differences among samples.  No effect was found for expectancy.  
These findings are important because they suggest possible mechanisms for maximizing 
treatment effects in medical and psychological settings, where factors such as nonspecific 
treatment effects and placebo are believed to influence outcomes.  Future research should 
seek to further clarify the relationship of expectancy and motivation to placebo outcomes, 
examining mediating factors such as attention, and carefully manipulating both variables 
to ensure maximum effects.  
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INTRODUCTION 
 
Research on placebo largely began in the mid-20th century and has since been 
examined in a wide variety of phenomena across multiple disciplines (Moerman, 2002).  
Placebo is broadly conceptualized as an inert substance which produces beneficial change 
and is loosely related to phenomena such as the Hawthorne effect (Wickstrom & Bendix, 
2000) and to the therapeutic effects associated with constructs such as hope (Richman, 
Kubzansky, Maselko, Kawachi, Choo, & Bauer, 2005), optimism (Scheier & Carver, 
1992), and more controversially, religiosity (Levin, 1996).  Traditionally, placebo effects 
have been most often studied in psychological and medical disciplines.  Placebo has been 
found to be an important component of treatments including psychological and 
pharmacological treatment of depression (Kirsch & Sapirstein, 1998; Lambert & Ogles, 
2004), surgeries such as transplant surgery for Parkinson’s (McRae, Cherin, Yamazaki, & 
Diem, 2004), acupuncture (Patel, Gutzwiller, Paccaud, & Marazzi, 1989), and smoking 
cessation interventions (Webb, Hendricks, & Brandon, 2007), to name a few.  In fact, in 
some cases, placebo has been found to be just as effective as commonly established 
‘active’ treatments.  For example, active placebo pills, which mimic the side effects of 
antidepressants, have been found to be nearly equally as effective as antidepressants in 
the treatment of depression, inciting controversy over whether or not antidepressants have 
specifically active treatment mechanisms (Moncrieff, Wessly, & Hardy, 1998).  Research 
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on active placebo highlights the subtle methodological variations which can greatly 
influence the power of the placebo in different contexts.   
Because placebo is a broad phenomenon which has been studied across various 
disciplines, definitions of terms such as “placebo response” and “placebo effect” often 
vary by author.  In the broadest sense, “placebo” is conceptualized as any substance or 
procedure which has no inherent power to produce the effect which is sought (Stewart-
Williams & Podd, 2004).  The “placebo effect”, then, can be conceptualized as a 
physiological, behavioral, or perceptual effect that can be attributed to placebo.  “Placebo 
responses” are responses on outcome variables in those persons receiving placebo.  Thus, 
although placebo effects are attributed to a substance or procedure, they do not result 
from inherent powers of the substance or procedure; instead, they are produced through 
learning or beliefs related to the placebo (Stewart-Williams & Podd, 2004).  In many 
studies of placebo, the established treatment is often referred to as an active treatment 
having specific effects, whereas placebo is deemed an inert treatment with nonspecific 
effects.  Some have argued that classifying placebo as “inert” unfairly characterizes 
placebo as having no true effect, a designation which is contrary to the vast body of 
literature demonstrating consistent and powerful effects for placebo (Stewart-Williams & 
Podd, 2004).  Moreover, others have argued that the labeling of placebo effects as 
nonspecific merely represents our current lack of understanding of placebo mechanisms 
and will likely change as researchers continue to provide new evidence on how placebo 
effects are produced (Kirsch, 1978).   
Effect sizes of placebo vary widely by setting and there is evidence to suggest that 
placebo effects can be produced by a variety of different mechanisms (Stewart-Williams 
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& Podd, 2004).  Many factors have been found to relate to placebo responding including 
characteristics of the clinician, the patient, the environment, and the placebo itself (e.g., 
Geers, Kosbab, Helfer, Weiland, & Wellman, 2007; Buckalew & Ross, 1981).  Most of 
these variables have been examined within the context of an expectancy model and there 
is some evidence to suggest that these factors influence placebo responding through 
altering expectancy.  Some recent theoretical models of placebo responding have 
included expectancy and motivation as the main mechanisms of change in placebo 
responding (e.g., Geers, Weiland, Kosbab, Landry, & Helfer, 2005).  These expectancy-
motivational models may help to explain why effect sizes of the placebo effect vary so 
widely; when all of the right person and situation factors are present, expectancy and 
motivation are maximized, thus producing maximum placebo effects.  However, where 
these important variables are missing, placebo effects are small.   
 
Factors that Influence Placebo Responding 
 
Environment and Placebo Characteristics 
Placebo has been found to be especially strong in medical settings where 
environmental cues and aspects of the placebo treatment itself can lead to increased 
placebo responding.  Simply being in the presence of medical equipment has been found 
to increase responding to placebo (Ernst, 2001).  Aspects of the placebo including color, 
taste, size, dosage, and mode of administration can also influence responding.  For 
example, research has found that blue placebo pills produce greater sedative effects than 
pink and that red placebo pills work better as stimulants than blue (Buckalew & Ross, 
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1981).  The association between color and therapeutic effect is likely due to the generally 
held mental representations of blue as being soothing and red as energizing.  These are 
associations which are formed through previous experience and may shape the 
therapeutic expectations subjects hold for placebo pills.  Taste has also been found to 
influence placebo responding, with more bitter tasting pills generally producing stronger 
placebo effects (Buckalew & Ross, 1981).  
Additional research on placebo responding has further demonstrated the 
importance of environmental and placebo factors in shaping placebo effects.  For 
example, research has demonstrated that people expect tailored smoking-cessation 
interventions to be more helpful than generic interventions and also benefit more when 
they are told that they are participating in a tailored intervention, even when the 
intervention is identical to the generic intervention (Webb, Hendricks, & Brandon, 2007; 
Webb, Simmons, & Brandon, 2005).  One explanation is that these subjects had 
previously formed expectations of the superiority of tailored interventions which, when 
primed in the lab, produced greater responding to the intervention.  The importance of 
previous experience in shaping placebo response was observed in one study which found 
that positive experience with placebo increased responding to placebo in later trials 
(Voudouris, Peck, & Coleman, 1985).  This study experimentally manipulated the 
perceived effectiveness of a placebo analgesic cream in reducing pain by reducing the 
shock intensity when the placebo cream was applied in earlier trials.  Participants who 
engaged in the earlier conditioning trial showed significantly greater pain reduction in 
later trials from the placebo cream than the group that had not experienced the 
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conditioning phase.  Thus, learning to associate the placebo cream with pain reduction 
increased later placebo responding.   
The research reviewed thus far suggests that associations of certain environmental 
and placebo factors with therapeutic benefit can increase placebo response.  These 
associations appear to be triggered by environmental or experimenter cues in the lab and 
may be enhanced in those treatments, such as antidepressant drugs, where strong 
associations have been established through previous experiential learning or sources such 
as the media and advertising.  In fact, research examining placebo in antidepressant drugs 
has found that the effect size of placebo responding has increased dramatically, along 
with the effect size for antidepressants, over the past 20 years (Walsh, Seidman, et al., 
2002).  One interpretation of this finding is that the public has become increasingly aware 
of psychopharmacological interventions through sources such as the media.  Drug 
companies have greatly expanded marketing of antidepressant drugs and awareness and 
acceptance of these drugs to treat psychological disorders such as depression is 
increasing.  It is possible that increased awareness and changing public perception has led 
to widespread associations of psychopharmacological drugs with therapeutic benefit. 
These findings underscore the importance of experience in shaping placebo effects.     
 
Experimenter Factors 
The clinician or experimenter can also influence placebo responding, oftentimes 
unintentionally.  In experimental studies, if the clinician or experimenter is aware of the 
group to which the subject is assigned, they may unwittingly communicate expectations 
of success to the subject, or encourage responses that are consistent with hypothesized 
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effects.  The importance of clinician factors in placebo was demonstrated in a meta-
analysis of medical treatments which were widely believed to be effective, but were later 
found to be ineffective (Roberts, Kewman, Mercier, & Hovell, 1993).  Despite the 
ineffectiveness of the interventions, initial research studies reported good or excellent 
outcomes in 45% to 89% of the patients, across studies.  In later research, all of these 
interventions were demonstrated to be ineffective, raising concerns about the 
methodological rigor in medical treatment trials.  The authors of this article posited that 
expectancies of the therapeutic effectiveness of these interventions largely influenced the 
earlier findings.  It is also likely that motivation for successful outcomes, both among 
clinicians and patients influenced outcomes.  Desire for beneficial change and belief in 
the effectiveness of the intervention was enough to produce positive change among many 
patients, despite the fact that the treatment itself had no real therapeutic effect.  This 
review demonstrates the power of placebo when expectancy factors are maximized.  
Earlier meta-analyses have found that about 35% of people respond to placebo (e.g., 
Beecher, 1955).  This study demonstrated that this response rate can be increased when 
expectancy among clinicians and patients is high. 
The important influence of experimenter factors in influencing treatment 
outcomes has also been demonstrated in psychotherapy research.  Specifically, 
experimenter allegiance to clinical treatment orientation and theoretical models has been 
found to be related to outcomes in several studies.  One meta-analysis of 58 studies on 
depression treatment found that theoretical allegiance was significantly related to effects, 
such that when the researcher’s allegiance was aligned with the treatment, that treatment 
was found to be more successful for treating depression (Robinson, Berman, & 
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Neimeyer, 1990).  A second meta-analysis which used self-assessment of theoretical 
orientation, peer-assessment, and research samples (theoretical orientation in other 
research articles by the same author) in assessing allegiance found similar results 
(Luborsky & Barrett, 2006).  The average of these three allegiance ratings correlated .85 
with outcome measures; thus, nearly 2/3 of the variability in treatment outcome could be 
attributed to theoretical allegiance.  The allegiance variable examined in these meta-
analyses may capture the expectancy and motivation factors that have been linked to 
placebo responding.  Experimenters likely expect the treatments aligned with their 
theoretical orientation to be more successful and are more motivated for these treatments 
to work.  Moreover, it is possible that these expectancies and motivations are 
communicated, either intentionally or unknowingly, to participants.  This likely increases 
the participants’ own expectancies regarding the therapeutic nature of the intervention 
and may also allow for factors such as demand characteristics to more easily influence 
results.   
   
Personality 
 In addition to situational factors, individual factors such as personality have been 
examined in placebo responding; many personality factors have been found to relate to 
placebo responding and the inclusion of these factors in a placebo model helps to provide 
a more comprehensive understanding of how the placebo effect occurs.  Personality 
factors which have been studied within the context of placebo responding include factors 
such as optimism, suggestibility, social-desirability, and religiosity.  For example, it has 
been found that optimists respond better to placebo than pessimists (e.g., Geers, Kosbab, 
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Helfer, Weiland, & Wellman, 2007).  Similarly, both religiosity and social desirability 
have been found to relate to placebo responding; some research has found that people 
who are high on these personality variables are more likely to respond to placebo 
analgesia (Gelfand, Gelfand, & Rardin, 1965; Hyland, Whalley, & Geraghty, 2007).  An 
additional study found that people high on spirituality had greater responding to a 
placebo relaxation intervention.   
Research has also demonstrated that high placebo responders are often higher on 
the trait of suggestibility (e.g., Pascalis, Chiaradia, & Carotenuto, 2001).  In a study 
which manipulated expectancy for a placebo analgesic cream, a graded response was 
found between suggestibility and expectations, such that those high in suggestibility had 
greater expectancies than the mid-level suggestibility group, which in turn, had greater 
expectancies than low-level suggestibility (Pascalis, Chiaradia, & Carotenuto, 2001).  In 
this study, these expectations were then translated into placebo responding in that higher 
expectancies were related to higher placebo responding.  This research suggests that the 
way in which suggestibility leads to greater placebo responding is through increased 
expectancies.  Other research which has examined personality and placebo responding 
has found that expectancy and motivation factors explain most of the variance in the 
relation between personality and placebo responding (Hyland, Whalley, & Geraghty, 
2007; Kirsch & Braffman, 2001).   
Although much research has demonstrated that certain personality traits can 
influence placebo responding, these findings have often been found to be inconsistent.  
For example, religiosity has been found to relate to placebo responding in some studies 
(e.g., Gelfand, Gelfand, & Rardin, 1965), but not others (e.g., Lansky & Phil, 1976).  
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Inconsistencies in findings suggest that personality effects in placebo responding change 
by context.  If the relationship between personality and placebo response is at least 
partially explained by changes in expectancy and motivation, this may provide an 
explanation for the inconsistent findings in the literature.  When people with certain 
personality traits are confronted with the right situational factors, this may trigger higher 
expectancies for change, thus producing greater placebo responses.  However, when these 
situational factors are not in place or when there is not a match between context and 
personality style, personality will not be a predictor of placebo responding.   
 
Placebo Outcomes 
 Various perceptual, behavioral, and physiological outcomes have been assessed in 
placebo research (e.g., McRae, Cherin, Yamazaki, & Diem, 2004).  Given that placebo 
effects can be produced through diverse mechanisms of change, it is reasonable to 
assume that placebo mechanisms may produce placebo effects which are detected by 
certain outcome variables, but not others.  In fact, research has found that in certain 
contexts, placebo effects are observed with only one type of outcome variable, but in 
other contexts, placebo effects are detected using multiple perceptual, behavioral, and 
physiological measures of placebo responding (e.g., Benedetti, Pollo, Lopiano, Lanotte, 
Vighetti, & Rainero, 2003).   
Some research, most notably in the area of placebo analgesia, has found 
convergence among different types of outcome measures.  Traditionally, research on 
placebo analgesic effects has assessed outcomes using self-report measures of pain.  
More recent research has sought to identify physiological correlates of self-reported 
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placebo analgesic effects.  This research has generally found that placebo analgesic 
effects are associated with reductions in neural activity in the areas of the brain which are 
known to process anxiety and pain (Price, Finniss, & Benedetti, 2007).  Research in 
clinical settings has also found consistency on physiological and self-report measures.  
One study in which Parkinson’s patients were given either a transplant surgery or a sham 
surgery (placebo) found that patients in the placebo group improved on both self-reported 
well-being and measures of motor movement (McRae, Cherin, Yamazaki, & Diem, 
2004).  Thus, in some settings, consistent effects can be found on perceptual, behavioral, 
and physiological assessments of outcome.   
However, other research has found that in certain contexts, expectancy and 
conditioning produce different placebo outcomes which may not be reliably assessed 
with all types of outcome measures.  For example, one study compared the effects of an 
expectancy and a conditioning manipulation on both perceptual and physiological 
outcome measures (Benedetti, Pollo, Lopiano, Lanotte, Vighetti, & Rainero, 2003).  In 
the expectancy manipulation, verbal expectancies were given for the analgesic benefits of 
an intravenously administered saline solution.  In the conditioning manipulation, a 
placebo saline solution was conditioned with an intravenous analgesic drug.  Placebo 
response was assessed through both self-reported pain and hormone secretion.  This study 
found that both expectancy and conditioning manipulations produced placebo 
responding, as assessed by self-reported pain perception, but only the conditioning trials 
induced a placebo response as assessed by changes in hormonal secretion.  This study 
suggests that some physiological markers of placebo are observed when conditioning, but 
not expectancy, is used.   
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One explanation for these findings proposes that physiological processes more 
highly associated with cognition and emotion may be more easily altered by expectancy 
manipulations (Benedetti, Pollo, et al., 2003).  For example, expectancy has been found 
to be consistently related to changes in the pain-processing area of the brain; there is a 
direct link between cognition, emotion, and brain activity.  However, other processes, 
such as hormonal secretion, appear to be less easily linked to cognitive and emotional 
processes.  It is possible that expectancy can produce outcomes related to conscious 
physiological processes but not unconscious physiological functions (Benedetti, Pollo, et 
al., 2003).  Conscious physiological processes would include processes such as pain 
perception and motor performance, which can more easily be conceptualized within a 
cognitive-emotional model.  This may help to explain why expectancy has been found to 
affect some biological markers, but not others.   
These findings are consistent with earlier work in learning which demonstrated 
that certain bodily functions over which an individual has no control, specifically smooth 
muscle or glandular responses, are altered through the process of conditioning, outside of 
one’s awareness (Skinner, 1981).  Other bodily functions over which an individual has 
more control, such as movement of striated muscles, can be altered through operant 
conditioning, within one’s awareness.  Similar to research findings on placebo 
mechanisms, operant learning and classical conditioning appear to act on different 
pathways, leading to different types of responses.  The existence of multiple pathways in 
placebo should not diminish the importance of one outcome variable or pathway relative 
to another.  Each is important in gaining more complete understanding of a person’s 
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overall experience and will hopefully help to inform a more inclusive and comprehensive 
model of placebo.    
 
Summary 
 The overall model suggests that a complex interplay of multiple environmental, 
experimenter, and person factors interact to produce placebo responding.  Certain factors, 
such as mode of placebo administration, consistently influence placebo effects, whereas 
others, such as personality, do not appear to be reliably related to placebo.  
Environmental and placebo factors may become associated with therapeutic benefit and 
influence placebo responding, either within awareness, as proposed by expectancy 
models, or outside awareness, consistent with conditioning models.  Thus, placebo is 
believed to be produced through multiple pathways and certain outcome variables may be 
more appropriate than others for detecting placebo responses, depending on the context.  
The complexity of factors and multiple mechanisms involved in placebo helps to explain 
the varied effect sizes observed in the literature and suggests a need for a comprehensive 
model of placebo.  
 
Models of the Placebo Effect 
Although research has examined various contextual factors which influence the 
strength of placebo effects, the specific mechanisms of change involved in placebo 
responding are less understood.  Two theories of the placebo effect which have gained 
the most support are the conditioning and expectancy models.  The conditioning model 
asserts that placebo responding occurs when a placebo (a neutral stimulus) is paired with 
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an unconditioned stimulus (UCS) that produces a response naturally, without 
conditioning.  After conditioning, the placebo becomes a conditioned stimulus (CS) and 
produces the conditioned response (CR) which was originally produced by the UCS.  
Unlike the conditioning model, the expectancy model does not require previous 
experience with the stimuli.  Instead, the expectancy model asserts that placebo 
responding occurs when people have expectancies about the beneficial nature of a 
placebo and that these expectations are responsible for producing placebo effects 
(Stewart-Williams & Podd, 2004).  
These two models of placebo are not necessarily incompatible.  Often, findings in 
the placebo literature are presented as supportive of either a conditioning or an 
expectancy perspective, when many of these findings can be explained equally well by 
both theories (Stewart-Williams & Podd, 2004).  For example, it has been observed that 
placebo analgesic effects are stronger when the placebo is administered via injection than 
when administered orally through a placebo pill (Kaptuchuk, Goldman, Stone, & Stason, 
2000).  This observation could be explained by findings in the conditioning literature 
which demonstrate stronger unconditioned stimuli leading to stronger conditioned 
responses.  However, expectancy theory could provide an equally plausible explanation; 
people expect injections to have stronger effects than pills and these expectancies 
produce stronger placebo responses.  In a qualitative review of expectancy and 
conditioning placebo effects, the authors concluded that expectancies are involved in 
some examples of conditioning, whereas in other contexts, more ‘pure’ forms of either 
theory can best explain placebo effects (Stewart-Williams & Podd, 2004).    
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In some contexts, it is believed that the process of conditioning produces 
expectancies, which in turn, lead to the expected outcome.  In support of this assertion, 
research has demonstrated that participants’ expectancies about the conditioning 
relationships can influence the conditioning process (Unger, Evans, Rourke, & Levis, 
2003).  Theorists in favor of cognitive interpretations of conditioning point to this 
research as evidence that the learning involved in placebo responses occurs through the 
acquisition of expectancies (Stewart-Williams & Podd, 2004).  However, conditioning 
can also produce placebo responding in the absence of expectancies.  Several studies 
have demonstrated that conditioned placebo responses can be produced even when 
participants are unaware of the conditioned and unconditioned stimuli, and thus, are 
unable to form expectancies of outcomes (e.g., Benedetti, Pollo, Lopiano, Lanotte, 
Vighetti, & Rainero, 2003).  There is also research which demonstrates that expectancies, 
in the absence of conditioning, can produce placebo responding.  For example, research 
on asthma has found that the same placebo (inhaler) can produce vastly different placebo 
responses depending on the verbal expectancies given to participants (Butler & Steptoe, 
1986).  Thus, the differences in placebo responses were not due to conditioning, but 
rather the verbal expectancies communicated to participants at the beginning of the study.   
The research reviewed thus far provides evidence that neither expectancy nor 
conditioning models alone can fully account for the diverse effects in placebo literature.  
Both expectancy and conditioning have been found to play an important role in the 
placebo effect and evidence suggests that they may act on different pathways.  When 
both expectancy and conditioning are employed, placebo responding is increased.  A 
meta-analysis which compared the effect sizes of both conditioning and expectancy 
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factors found that in that studies where placebo analgesia was induced by expectancy or 
conditioning alone, effect sizes were about .85 (Vase, Riley, & Price, 2002).  However, in 
studies where both expectancy and conditioning were used to induce placebo responding, 
the effect size was 1.45.  Moreover, in studies where conditioning and expectancy effects 
are in opposite directions, overall placebo effects disappear.  For example, one study used 
conditioning to produce placebo analgesia, as assessed by changes in hormone secretion 
(Benedetti, Pollo, Lopiano, Lanotte, Vighetti, & Rainero, 2003).  When hyperalgesia 
expectancies were induced through statements indicating that the treatment would 
actually increase pain, the effects of the conditioning disappeared.  Thus, it appears that 
placebo effects are maximized when expectancy and conditioning are both used to elicit 
placebo response and minimized when expectancy and conditioning effects are in 
opposite directions (e.g. conditioning analgesia with expectancies for hyperalgesia).  
In conditioning models, there is little focus on mechanisms of change; support for 
these models is found in the measurement of objective outcomes (Stewart-Williams & 
Podd, 2004).  Expectancy models, which focus on internal processes and mediating 
behaviors, posit possible mechanisms of change in placebo.  Research demonstrates that 
expectancies do play an important role in conditioning, although not all conditioning 
requires expectancy.  In some contexts, expectancy appears to produce placebo 
responding in the absence of conditioning.  Thus, it appears that expectancy is an 
important factor in the placebo effect and that expectancy models can account for placebo 
effects in a wide range of contexts.  The current study examined placebo responses within 
the context of expectancy models (see Table 1).    
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One model of placebo proposes that expectancies lead to greater attention to signs 
of improvement, which in turn leads to placebo responding (Lundh, 1987).  Placebo 
effects are then used as further evidence to support placebo expectations, increasing 
future placebo responding.  There is some research which has demonstrated that somatic 
focus, or attention, is important in producing placebo responding.  In one study, 
participants were given a placebo pill which was said to have symptoms of nausea and 
headaches.  The participants who were told to focus on their bodily reactions during the 
15 minutes after taking the pill had stronger placebo responding than those who were not 
told to attend to these symptoms (Geers, Helfer, Weiland, & Kosbab, 2006).  Thus, 
increasing attention to symptoms may cause people to selectively focus on sensations 
consistent with their placebo expectations and to interpret ambiguous sensations as 
consistent with expectations.   
Although traditional expectancy theory has some empirical support, it is unable to 
account for the diverse array of outcomes in placebo research.  Alternate expectancy 
models of placebo responding have included motivational factors in order to better 
explain placebo outcomes.  For example, the goal-activation model of the placebo effect 
asserts that placebo responding is produced when expectations are compatible with 
motivation (Geers, Weiland, Kosbab, Landry, & Helfer, 2005).  Motivational forces 
examined within the context of expectancy-motivation placebo models include demand 
characteristics, self-enhancing motives, and the motivation to feel better.  These more 
complex models of placebo have had some initial support and provide more compelling 
explanations of placebo responding.   
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Expectancy-motivation theories of placebo can account for several findings in the 
placebo literature that are not easily explained by more traditional expectancy theories.  
For example, research has found that there are greater placebo responses in research on 
clinical pain versus experimental pain, even when controlling for initial pain severity 
(Price, Milling, Kirsch et al., 1999).  Participants in clinical samples are often 
experiencing chronic, long-standing pain and may be more invested in analgesic 
treatment than participants in experimental studies who are reporting equal levels of pain 
severity.  If motivation to reduce pain influences placebo responding, as proposed by 
expectancy-motivational models of placebo responding, this may explain why clinical 
studies of pain typically have larger effect sizes.   
Several studies have directly assessed expectancy and motivation variables in the 
context of placebo responding.  One experimental study found that expectancy and 
motivation interact to produce placebo responding such that at high levels of motivation, 
placebo responding occurs, but at low levels, it does not (Geers, Weiland, Kosbab, 
Landry, & Helfer, 2005).  In this study, trials with the highest effect sizes were those 
where expectancy and motivation variables were maximized.  Other research on 
expectancy-motivation models has found more mixed support.  In two other studies 
which assessed both motivation and expectancy, one study found that motivation, but not 
expectancy, influenced placebo responding (Jenson & Karoly, 1991) and one study found 
that expectancy, but not motivation, influenced placebo responding (Price, Milling, 
Kirsch, Duff, & Montgomery, 1999).   
An examination of the moderators and mechanisms of the placebo effect can help 
to reconcile this apparent contradiction.  As previously discussed, pain ratings are often 
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higher in clinical versus experimental settings.  In the Price et al. (1999) study, pain 
ratings were assessed in an experimental setting with a college student population and 
motivation was characterized as the desire to reduce the pain.  If the anticipation of and 
actual experience of pain was minimal, it is likely that participants would have had less 
motivation to reduce pain, providing a possible explanation for the findings that 
expectancy, but not motivation, influenced placebo responding.  Jenson and Karoly 
(1991) similarly utilized an experimental lab design with student populations, but instead 
of the motivation to reduce pain, examined self-enhancing motivation.  It is reasonable to 
assume that self-enhancing motives and demand characteristics can be more easily and 
reliably manipulated in a lab setting than the motivation to reduce pain, especially when 
working with a generally healthy college student population.  This may help to explain 
why motivation, but not expectancy, was found to influence placebo responding in 
Jenson and Karoly (1991).  This analysis is consistent with research on moderators of 
placebo responding which have identified various situational and person variables that 
influence placebo effects.  These moderating variables, including characteristics of the 
subjects (i.e. clinical vs. experimental populations) may differentially influence 
expectancy and motivation variables, thereby influencing placebo responding.   
Although there is research to support the importance of motivation in placebo 
responding, less is known about how expectancy and motivation work together to 
produce placebo effects.  A more comprehensive model of placebo responding which 
includes potential mechanisms of change in placebo responding is the desire-expectation 
model.  This model is based on theories of emotional experience and includes motivation, 
expectancy, attention, and emotion (Vase, Price, Verne, & Robinson, 2004).  The desire-
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expectation model proposes that high desire (or motivation) and expectancy leads to 
initial signs of relief at the beginning of the placebo response.  When presented with a 
stimulus, such as a painful shock, the patient experiences negative affect.  As the patient 
begins to notice that the treatment (e.g. placebo analgesic cream) is working, expectation 
for relief increases and motivation for relief decreases.  The lowered desire for relief and 
increase in expectation results in less negative feeling, which enhances placebo response.  
This model has found some initial support in research which has examined model 
variables at different points throughout the placebo response.  Specifically, one study 
found that that the placebo effect increased overtime as expected pain intensity, desire for 
pain relief, and anxiety decreased (Vase, Price, Verne, & Robinson, 2004).  Although this 
study demonstrated that each of these variables is related to placebo responding, the 
desire-expectation model does not clearly outline how these variables interact to produce 
placebo effects.  
Each of the three main expectancy theories outlined thus far has overlapping 
elements (see Table 1).  The goal-activation model and the desire-expectation model 
propose that motivation and expectancy are both important elements in producing 
placebo responses.  The desire-expectation model and Lundh’s (1987) expectancy model 
propose that attention moderates responding.  Specifically, the desire-expectation model 
suggests that motivation and expectancy lead to greater attention, although the process by 
which this occurs is not clearly stated.  The expectancy model proposes that expectancy 
leads to greater attention of relevant body sensations, which are interpreted consistent 
with expectations, thereby producing placebo responses (Lundh, 1987).  Together, these 
three placebo models posit that motivation, expectancy, and attention are important 
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variables in the placebo response and that motivation and expectancy factors may 
influence placebo responding through increased attention to relevant stimuli.  However, a 
major shortcoming of each of these models is that they do not clearly outline how each of 
these important variables work together to produce placebo effects.   
Although placebo models have included attention as a potential mediator in 
placebo effects, this process is poorly defined and ill-understood.  For example, the 
desire-expectation model, which is the only model to include all three variables 
(motivation, attention, and expectancy) provides only a general explanation of proposed 
mechanisms and does not describe the unique contributions motivation and expectancy.  
Moreover, this model is limited in that it conceptualizes placebo as emotional experience 
and does not account for the wide variety of placebo responses observed.  Both 
expectancy and motivation factors have been found to be important variables in placebo 
research and an understanding of the contribution of each in producing placebo effects is 
important in developing a clearer understanding of placebo mechanisms.  
 
Motivation and Attention 
Research on attention, motivation, and interpretive biases may provide further 
insight into the process through which expectancy and motivation influence placebo 
effects.  Research suggests that our perception of the world is influenced by two 
important processes: 1) perception is selective in that people selectively attend only to 
certain stimuli in their environment and 2) perception is biased in that attended to stimuli 
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are interpreted in a biased fashion.1  Beginning with the New Look theorists of the 1940s 
and 1950s, a large body of research has emerged on the important influence of attitudes, 
motivation, and expectancies on perception (Erdelyi, 1974).   Although much of this 
research has been widely accepted and influential in the fields of cognitive and perceptual 
psychology, work on motivational influences was not as well received (Balcetis & 
Dunning, 2006).  Research on motivation and perception was widely criticized on 
methodological and theoretical grounds and fell out of favor in the 1950s (e.g., Bruner & 
Goodman, 1947).  Despite earlier criticism, research on motivation and perception has 
seen a recent resurgence, with many newer studies addressing the methodological 
shortcomings of past research.  Motivation has been found to affect both attention to and 
interpretation of a wide variety of stimuli including the perception of visual and 
emotional stimuli, memory processes, and judgments of others (e.g., Balcetis & Dunning, 
2006).     
First, motivation has been linked to attention, in that people are more likely to pay 
attention to stimuli that are consistent with their desires (Balcetis & Dunning, 2006).  For 
example, in forming impressions of others, people often quickly place others in 
categories of familiar social groups because this strategy requires little time and cognitive 
resources.  However, when people are motivated to form particular impressions of others, 
this process of categorization is replaced by other strategies of impression formation.  
Research on social judgments has provided insight into how motivational processes result 
in selective attention (Berscheid, Graziano, Monson, & Dermer, 1976).  In this research, 
                                                 
1 Although these changes in perception often referred to as ‘biased’, this term should be interpreted 
carefully, as some changes in perception result in more accurate perceptual judgments.     
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motivation is often assessed through the concept of outcome dependency, or the 
relevance of the outcome to the individual.  In one study on dating relationships, college 
students with the greatest outcome dependency and greatest motivation to like potential 
dates paid most attention to their future date and reported greater liking of the date 
(Berscheid, Graziano, Monson, & Dermer, 1976).  One interpretation of these results is 
that the greater observations made by those in the high outcome dependency group were 
interpreted in a biased fashion, consistent with students’ motivations to have a desirable 
date.   
Other research which has examined attention under conditions which promote 
more accurate judgments of others has found additional evidence in support of the 
motivation-attention link.  For example, one study found that when subjects are 
motivated to form more accurate perceptions of others, they typically pay more attention 
to information inconsistent with their expectations, when compared with students who are 
not motivated to accurately judge the other person (Erber & Fiske, 1984).  It is posited 
that when people are motivated to form more accurate judgments, they pay attention to 
disconfirming evidence as well as confirming evidence and are less influenced by 
perceptual bias.  This research provides additional support for the assertion that 
motivation influences attention to stimuli.  Lastly, the motivation-attention link has been 
found in other research, including research on motivation and emotional experience.  One 
study found that participants manipulated to regulate emotion selectively attended less to 
emotionally charged stimuli following the manipulation (Xing & Isaacowitz, 2006).   
As further evidence for the importance of motivation in perception, there is 
research which demonstrates that the perceptual process involved in many everyday 
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judgments is driven by motivational variables (McMullen, Fazio, & Gavanski, 1997).  In 
making probabilistic judgments, people often fail to account for base rates.  For example, 
when a patient presents with a symptom, such as a cough, the doctor could access two 
different sample spaces, or disease populations, in making a diagnosis.  First, they might 
think of the population of people with disease X they have treated, realizing that 70% of 
these people had a cough.  Second, they could think of the population of people known to 
have that symptom (90%) and the proportion of these people known to have disease X 
(1%).  In the first example, the doctor neglects base rates and using this sample space in 
diagnostic decision-making would result in over-diagnosis of diagnosis of disease X.  
The second example accounts for base rates and if used, would likely result in a more 
accurate diagnosis.  Although neglect of base rates is often viewed as an automatic error 
in judgment common to most people, research has found that motivation influences the 
use of base rates in decision-making.  McMullen, Fazio, and Gavanski (1997) found that 
when people are motivated to find one particular characteristic, they often use the 
population containing this characteristic as the base rate population in making 
probabilistic judgments.  This study provides further evidence for the role of motivation 
in increasing attention to relevant or desired characteristics.  Moreover, this study 
provides evidence for the assertion that motivation plays an important role in attention, 
even in more common, everyday judgments, where motivational factors may not be as 
easily identifiable.   
The research examined thus far has demonstrated that motivation can influence 
attention to relevant stimuli.  There is also research which has demonstrated that 
motivation influences the interpretation of information attended to, often resulting in 
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interpretive biases.  One study found that students interpreted ambiguous stimuli in a way 
that confirmed several manipulated motivational states including the motivation to think 
about one’s prospects in a favorable way, the motivation to achieve valuable outcomes, 
and the desire to enhance self-esteem (Balcetis & Dunning, 2006).  Other research on 
visual perception has found similar results.  For example, one study which examined the 
motivation to resolve cognitive dissonance manipulated the degree to which students felt 
that they had freely chosen to complete an embarrassing task (i.e. running a short distance 
across campus wearing a costume inspired by Carmen Miranda, pushing themselves 
uphill while seated on a skateboard), presumably creating high cognitive dissonance 
among those students who completed the task when there was little pressure to do so 
(Balcetis & Dunning, 2007).  This study found that students experiencing high cognitive 
dissonance rated the distance run to be shorter and the slope of the hill to be less steep, 
supporting the assertion that the motivation to reduce cognitive dissonance biased their 
perception of the environment.  Similar links between motivation and interpretive biases 
have been found in research on social judgments.  In the Berscheid, Graziano, Monson, & 
Dermer (1976) study described above, not only did students pay greater attention to 
potential dates when outcome dependency was high, but they also rated potential dates as 
more likeable and reported being more attracted to the potential date.  Thus, not only 
does motivation alter the environmental and internal stimuli attended to, but it also skews 
our interpretation of these stimuli.    
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Current Study 
Research provides evidence that both motivation and expectancy are important 
variables in producing placebo responding.  The process by which expectancy and 
motivation interact to produce placebo responses has undergone less theoretical and 
empirical examination.  The current study, drawing on research in motivation and 
perception, proposes a model in which these two important variables interact to produce 
placebo responses (see Figure 1).  There is strong evidence in the perception literature 
that motivation influences attention to stimuli and the interpretation of stimuli, providing 
support for a placebo model in which motivation causes increased attention to placebo-
relevant stimuli, leading to a placebo response.  When people are motivated for a 
treatment to work, they selectively attend to stimuli which support their motivations and 
interpret ambiguous stimuli in accordance with motivation.  Moreover, some theorists in 
the perceptual bias literature have proposed that expectancies inform people of testable 
perceptual hypotheses (Balcetis & Dunning, 2006).  Thus, motivation may increase 
attention to and processing of stimuli, but expectancy may help to inform the possible 
interpretations of these stimuli.  This would be consistent with literature linking 
motivation to attention and with placebo literature demonstrating the importance of both 
expectancy and motivation in influencing placebo responses.   
The current model proposes that attention or diligence is the mechanism through 
which motivation leads to greater placebo responding; expectancy also influences 
placebo responding, but does not do so through attention (see Figure 1).  In the typical 
experimental study of placebo, participants are given a placebo treatment and are led to 
believe, either through verbal suggestion or the contextual factors discussed previously, 
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that the treatment will be effective in achieving some end.  A person who is highly 
motivated for the intervention to work may be more diligent in attending to relevant 
stimuli.  They may interpret these stimuli according to expectations, thus compiling more 
‘evidence’ of the treatment’s success and resulting in increased placebo responding.  A 
second person, who has little motivation for the placebo to work, may pay little attention 
to signs of the placebo’s ‘success’ throughout the experiment, thus finding little evidence 
for the effectiveness of the placebo intervention.  In each case, it is possible that both 
subjects had equal expectancy for the placebo’s effectiveness; however, one subject was 
motivated to look for signs of success, whereas the other was not.  Changes in 
expectation may also influence the placebo response.  At high levels of expectation, a 
highly motivated person will likely find even greater signs of ‘success’ whereas lower 
levels of expectancy might reduce the impact of the intervention, even for a person who 
is more highly motivated.  This model provides an explanation of the processes through 
which expectancy and motivation lead to placebo response and is an improvement over 
previous models in its comprehensiveness and clear explanation of mechanisms.   
The current model’s emphasis on motivational factors is a slight departure from 
previous placebo research, where the focus has largely been on expectancy.  Studies 
examining the influence of expectancy on placebo often neglect to assess motivation, 
although motivational forces are likely present (e.g., Friedman, McCarthy, Barholow, & 
Hicks, 2007).  Moreover, many studies have manipulated expectancy only, thereby 
neglecting motivational influences and likely reducing the impact of the placebo 
(Voudouris, Peck, & Coleman, 1990).  There is little research which has examined the 
individual effects of expectancy and motivation and no research which has successfully 
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demonstrated that either is sufficient to produce placebo in the absence of the other.  
Indeed, it is unlikely that motivation factors could easily be reduced to zero in lab 
settings.  Moreover, it is also likely that each variable influences the other, at least to 
some degree.  Although little research has examined the bi-directional influences of 
expectancy and motivation, it seems reasonable to suggest that when motivation is high 
for a placebo to produce change, this may influence expectations of the placebo’s ability 
to produce this change.  Lastly, it is reasonable to assume that when both expectancy and 
motivation factors are high, placebo effects are maximized, an assertion which has found 
some support (e.g., Geers, Weiland, et al., 2005).   
Overall, the interrelations among expectancy, motivation, attention, and placebo 
have not been widely studied.  Moreover, the specific mechanisms through which these 
variables influence placebo effects have been explored in other models, but never clearly 
articulated.  The purpose of the current study is to examine the process through which 
these variables work together in producing placebo effects, with a focus on the potential 
mediator of attention.  A conceptual understanding of this process would provide a 
framework for future research examining the contribution of various factors in producing 
placebo effects.  
 
Study Design  
The current study has three central hypotheses: 1) motivation leads to greater 
attention to stimuli and task diligence, 2) the relationship between motivation and 
placebo response is mediated by attention/task diligence and 3) expectancy positively 
influences placebo response.  The study design allows for a test of these three hypotheses.  
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Both motivation and expectancy were manipulated and attention was assessed using two 
behavioral measures of task diligence.  The resulting research design is a 2x2 matrix, 
with high and low levels of both expectancy and motivation.  If motivation leads to 
greater diligence, which, in turn, leads to greater placebo response, this would provide 
evidence that attention (or diligence) is an important mechanism of change in placebo.  
Lastly, if expectancy influences placebo response this would provide evidence for the 
important role of both expectancy and motivation in placebo and would hopefully 
produce a better understanding of how these two variables interact to produce placebo 
effects.  
In the current study, placebo mechanisms were examined using a placebo 
pheromone.  Although the influence of pheromones on human behaviors is marked by 
contentious debate, pheromones have received wide public attention, a trend which is 
appealing when designing a study to examine placebo mechanisms.  The study of 
pheromones appears to have entered into the realm of popular culture, suggesting that 
there are generally held expectancies that pheromones influence sexual attraction.  In 
fact, a Google search of “pheromone cologne” or “pheromone perfume” produces 
hundreds of hits including several websites selling pheromone substances with the 
promise that they will increase one’s attractiveness to the opposite sex.   
Research studies comparing pheromones to placebo have generally found support 
linking pheromones to sexual behaviors in non-humans, although the relationship 
between pheromones and sociosexual behaviors in humans is considerably more tenuous.  
While some studies have linked pheromone exposure to outcomes such as increased 
attraction and sexual behavior (e.g., Gustavson, Dawson, & Bonett, 1987), other studies 
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have found no such effects (e.g., Benton & Wastell, 1986).  Typically in psychological 
research of pheromones, participants are exposed to a true pheromone and a placebo 
substance, commonly slightly scented water.  Although the verbal instructions given to 
participants are not always adequately described in these studies, it appears that some 
experimenters have given false explanations regarding the study’s purpose in order to 
reduce expectancies and demand characteristics.  For example, in one study which 
administered pheromones to participants using a mask, participants were told that the 
study purpose was to examine the effects of breathing on reading; thus, these participants 
were not aware that pheromones were being administered (Benton & Wastell, 1986).  If 
the participants were not aware of the study purpose, they could not form expectancies or 
motivations for particular outcomes.  Thus, it is reasonable to assume that when the 
purpose of the study is disclosed to participants, expectancy and motivation would be 
enhanced and overall effects would be larger.   
Indeed, there is some research in the pheromone literature to support this 
assertion.  First, one study in which participants were unwittingly given greater 
expectancies in one trial found that participants in this trial responded more highly to the 
pheromone than participants in later trials (Saxton, Lyndon, Little, & Roberts, 2008).  In 
this study, participants were recruited for a speed dating event in which members of the 
opposite sex communicated in dyads for brief intervals, giving participants the 
opportunity to become acquainted with several people throughout the course of the event.  
Participants in the first trial were told that experimenters were examining the effects of 
pheromones and attraction, whereas participants in the second and third trials were told 
that experimenters were examining odors and attraction.  It is possible that by specifically 
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mentioning pheromones, researchers induced greater expectancies among participants in 
the first trial, thus accounting for the greater pheromone response.  Moreover, the first 
speed dating event was composed of college students and the second two events were 
attended by members of the general public, having a much higher average age.  As 
physical attractiveness is generally found to be viewed as more important in dating 
among younger people, the researchers postulated that perhaps motivation for the 
pheromone to work was greater in the first trial than in the following trials.  If expectancy 
and motivation factors were indeed higher in the first trial, this may help to explain why 
effect sizes for all three experimental groups (pheromone, placebo + odor, and placebo) 
were higher in the first trial.   
Additional evidence for the role of expectancy, motivation, and placebo in 
pheromone research can be found in studies which have compared pheromones to 
different types of placebos.  The smell of the pheromone may or may not be detectable to 
participants, depending on the concentration of the pheromone used.  Psychosocial 
effects have been observed both at high and low concentrations.  Studies which use 
lower, generally undetectable, concentrations of pheromones likely reduce both 
expectancy effects and potential demand characteristics.  However, at higher 
concentrations, pheromones give off a musky odor, introducing potential confounds.  A 
few studies which have compared the effects of placebo musk, odorless placebo, and 
pheromone have found that the pheromone produces the greatest effect, followed by 
placebo musk, and lastly, odorless placebo (e.g., Filsinger, Braun, & Monte, 1985).  It 
has been proposed that the effects for placebo musk may be due to conditioning; people 
learn to associate perfumes and musk with attraction and thus, respond positively when 
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presented with these substances (Comfort, 1971).  It is also possible that musk substances 
produce expectancies for increased attraction or trigger demand characteristics by helping 
to reveal the study purpose to participants, thus increasing effect sizes.  Both the 
conditioning and expectancy explanations are consistent with a placebo model and 
produce further evidence that placebo may be a mechanism of change in pheromone 
effects.   
Given these findings, it is reasonable to assume that the pheromone research 
paradigm is an acceptable means for examining placebo mechanisms.  Moreover, given 
the current study context, pheromones provide added benefit for two main reasons.  First, 
the study of pheromones is within the realm of psychology; many research studies 
published in psychology journals have examined the effects of pheromones on 
sociosexual variables.  Moreover, sexual attraction, a variable which is widely linked to 
pheromones, is also linked to the study of psychology.  Thus, the study of pheromones 
and attractiveness within the context of psychology is likely a believable research 
endeavor to those participating in the study.  As previously discussed in the introduction 
section of this paper, there are several environmental cues which have been found to 
increase the effect of placebos.  When testing the effectiveness of a medical treatment, 
environmental cues, such as a hospital setting, the white coat of a doctor, and medical 
equipment, can increase expectancies for the effectiveness of this substance (Ernst, 
2001).  If a substance such as a placebo analgesia was tested in the psychology 
department where these cues were absent, this would likely be less believable to 
participants, thus reducing expectancies.  This problem is addressed by the use of a 
placebo pheromone study design.   
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A second advantage to using a placebo pheromone is that this procedure will help 
to maximize motivation.  In the current study, students who were not involved in a 
committed relationship were recruited for a study on “dating and attraction.”   The 
motivation to find a dating partner is a universal human motivation which has relevance 
to students even outside the lab setting (Maner, Matthew, Gailliot, Rouby, & Miller, 
2007).  Moreover, in the current study, students were told that they would be ‘matched’ 
with potential dates based on the results of a personality and attitude survey (although no 
actual date matching would occur).  The relation between similarity and variables such as 
attraction and liking has been widely studied and there is much evidence to suggest that 
we like those who are more similar to us (e.g., Byrne, 1997).  For example, giving people 
feedback which suggests that others share similar attitudes has been found to increase 
attractiveness towards that person (e.g., Schlenker, Brown, & Tedeschi, 1975).  The 
desire to perceive like-minded dates as attractive is one which occurs naturally and 
triggering this desire in a lab setting will likely increase the impact of the placebo 
pheromone.  In the current study, students in the high motivation group were told that 
their potential dates have been chosen for them based on the results of a personality 
survey, thus increasing similarity to the date.  Moreover, they were told that they will 
have the opportunity to meet this person by participating in a follow-up study.  Thus, the 
use of a pheromone placebo should help to produce both a believable and desirable 
outcome for participants. 
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METHOD 
 
Procedures 
Participants in this study consisted of undergraduate students enrolled in 
psychology courses at IUPUI who were not currently involved in a committed romantic 
relationship.  Students were recruited using the university’s Experimetrix website for a 
study on “dating and attraction” and received extra credit for participation.  Students were 
randomly assigned to one of the following four experimental groups: 1) high 
motivation/high expectancy, 2) low motivation/low expectancy, 3) low motivation/high 
expectancy, or 4) high motivation/low expectancy.  Research assistants conducted the 
experiments and were not informed of the research hypotheses.    
When students reported to the lab, they first filled out a questionnaire containing a 
personality inventory, relationship attitudes scale, optimism scale, social desirability 
scale, and demographic questionnaire (see Appendix A).  Participants were informed that 
the results of these surveys would be used to ‘match’ them to members of the opposite 
sex (students who identified as homosexual on the demographics questionnaire were told 
the samples were of the same sex).  They were given, depending on the experimental 
group to which they had been assigned, one of four sets of instructions, intended to 
introduce the study to participants and to manipulate motivation and expectancy (see 
Appendix C).  In the high motivation condition, students were informed that if they found 
the scent of their match to be most pleasing, they would have the opportunity to return to 
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the study at a later date with their match to participate in a second phase of the study (see 
Appendix B).  In the low motivation group, students were informed that the data 
collected in this study was for academic purposes only, the identities of their match 
would not be revealed, and that they would not have the opportunity to meet the potential 
dates.  In the high expectancy group, students were told that there is much research to 
suggest that pheromones can influence how attractive we find others and that people have 
been found to respond differently to the pheromones of others, suggesting the presence of 
‘chemistry’ between certain individuals (see Appendix B).  In the low expectancy 
condition, students were told that the research examining the influence of pheromones on 
attraction has been somewhat unfavorable, with only a few studies finding support for 
this relation and that people have a difficult time detecting the pheromone scents of 
others. 
After the introduction to the study and corresponding expectancy/motivation 
manipulations, students participated in the placebo pheromone task.  The placebo 
pheromone was identical for all four experimental groups and consisted of slightly 
scented water, consistent with other pheromone research.  Moreover, similar to the design 
in other pheromone research, samples of the pheromone were applied to a surgical mask 
(e.g., Kirk-Smith, Booth, & Davies, 1978).  Four identical samples of placebo pheromone 
were presented to all subjects.  Participants were told that one of the pheromone samples 
was from their ‘match’ and the other three were random samples taken from volunteers 
not involved in the study.  Students were asked to put on the mask and subsequently rate 
each of the four samples on arousal, attraction, and sexiness and then to select the best 
sample.  Students in all groups were told to take as much time as they need on these tasks 
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and that they may smell each sample as many times as they needed to in order to make 
their best assessments.  They were asked to make their final ratings of samples only when 
they felt that they had had sufficient time to make their ratings.  These ratings of arousal, 
attraction, and sexiness were then averaged to obtain an overall rating of desirability for 
each placebo sample.   
Two measures of attention were collected during this rating task.  First, attention 
was assessed as the total amount of time it took students to complete the entire rating 
task.  Time began once students were instructed to start the rating task and ended when 
students completed their ratings for all four samples and indicated to the experimenter 
that they were finished with the task.  A second measure of attention was assessed as the 
number of times students smelled each sample.  Because the samples were applied to 
surgical masks, students had to raise the mask to their nose in order to make assessments.  
It was assumed that those subjects who were most highly motivated for the pheromones 
to enhance arousal would take more time in assessing the samples (as measured by 
seconds taken to complete the task) and would make more assessments of each sample 
(as measured by the number of times each sample is smelled).  The more diligence with 
which subjects approach this task should provide more opportunity for subjects to 
interpret ambiguous feelings and physiological sensations according to their expectations 
and desires.    
The placebo response was assessed using two measurements.  The first measure 
of placebo response was the variability in ratings of desirability (overall desirability is the 
average of arousal, attractiveness, and sexiness) of the four samples.  Because each 
sample was exactly the same substance, greater variability in desirability ratings of these 
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samples should indicate greater placebo response.  This is consistent with other research 
on motivation and attention which has demonstrated that more highly motivated people 
tend to look for, and find, differences in ambiguous stimuli (Balcetis & Dunning, 2006).  
Secondly, placebo response was also assessed as the desirability rating for the selected 
sample.  Thus, it was assumed that students who responded more highly to the placebo 
pheromone would not only find more differences among identical samples, but would 
also rate their selected sample as higher in desirability, when compared to low placebo 
responders.   
Consistent with Hypothesis 1, it was expected that those subjects in the high 
motivation group would display more diligence on the rating task, thus taking longer to 
complete the task and smelling samples a greater number of times.  Consistent with 
Hypothesis 2, it was expected that attention/diligence would mediate the relationship 
between motivation and placebo response.  This would provide evidence for the role of 
attention as an important mechanism of change in placebo.  Hypothesis 3 states that 
expectancy will predict the two outcome variables of placebo response, but will not 
influence measures of attention and task diligence.  In other words, high expectancies for 
pheromone effectiveness should have a greater influence on the subjects’ interpretation of 
ambiguous stimuli, as indicated by a higher placebo response, than on task diligence, as 
measured by time engaged in the task and number of assessments made.   
These hypothesized results are consistent with a strong interpretation of the 
motivation-attention model in which only motivation influences attention.  As previously 
discussed, it is possible that expectancy would influence motivation and/or attention to 
some degree, leading to greater attention in the high motivation/high expectancy group 
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(as compared to the high motivation/low expectancy group).  In this more moderate 
interpretation of the model, motivation would have the largest influence on attention and 
expectancy would exert an influence on attention, but to a lesser degree.  An examination 
of potential interactions in the current model should produce a better understanding of the 
role that expectancy may play in task diligence.   
 
Measures 
 
Initial Survey 
 Although the main purpose of the pre-screening personality and attitudes survey 
was to increase the strength of the motivation manipulation, the measures selected for this 
survey are psychometrically sound and provided data for exploratory analysis.  The initial 
survey assessed general personality traits and attitudes pertaining to relationships and 
consisted of the Big Five Inventory (BFI), a relationship attitudes scale, the LOT-R, and a 
measure of social desirability.  Each of these surveys are face valid and should appear to 
students as a valid means of matching them with potential dates.  
 
The Big Five Inventory  
 The Big Five Inventory (BFI) is a 44-item test which assesses the Big 5 
personality traits.  The BFI provides a brief assessment of the Big 5 personality traits and 
is often used as an alternative to the NEO-R (Costa & McCrae, 1995).  The BFI has five 
subscales (extraversion, agreeableness, conscientiousness, neuroticism, openness) that 
assess different dimensions of personality.  Test takers are asked to determine how well 
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(from strongly disagree to agree strongly) a list of short descriptors (i.e. gets nervous 
easily) describes their personality (see Appendix A).  The BFI has been found to be 
internally consistent, with a Cronbach’s alpha values typically ranging from .75 to .90 
(Benet-Martinez & John, 1998).  The scale has also been found to be stable over time, 
with test-retest correlations ranging from .80 to .90.  As evidence of construct validity, 
BFI self-report scales have been found to correlate .61 with reports from family members 
and peers (Soto & John, 2009).  Moreover, BFI scales have shown convergent validity 
with Costa and McCrae’s (1995) factor definitions (Soto & John, 2009). 
 
Life Orientation Test- Revised 
The Life Orientation Test- Revised (LOT-R) is a 10-item self-report measure 
assessing generalized expectancies for positive versus negative outcomes (Scheier, 
Carver, & Bridges, 1994).  Because optimism has been found to relate (although 
unreliably) to placebo responding, this scale can be used in exploratory analyses 
following completion of the study.  The scale consists of three positively worded items 
(e.g. In uncertain times, I usually expect the best) and three negatively worded items (e.g. 
I hardly ever expect things to go my way) which are rated on a scale ranging from 0 
(strongly disagree) to 4 (strongly agree) (see Appendix A).  After reversing the scoring 
for the negatively worded items, the item scores are summed to yield an overall score, 
with higher scores reflecting greater optimism.  The LOT has been demonstrated to be a 
reliable and valid measure of optimism.  The scale is internally consistent, with a 
Cronbach’s alpha of .82.  Additionally, when compared to scales such as self-esteem and 
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self-mastery, the LOT appears to have adequate predictive and discriminant validity 
(Scheier et al., 1994).   
 
Relationship Attitudes 
 In order to increase the strength of the manipulation, students were asked a series 
of 10 questions assessing their attitudes and preferences regarding romantic relationships 
(see Appendix A).  These questions were compiled from a wide variety of scales such as 
the Conflict Communication Scale and were not intended to be scored.  The primary 
purpose of these questions was simply to increase the believability of the matching 
exercise.    
 
Social Desirability 
 The Crowne- Marlowe Social Desirability Scale consists of 33 true/false 
questions and is a commonly used measure of social desirability.  Items include a wide 
variety of behaviors, both desirable (e.g. no matter who I’m talking to, I’m always a good 
listener) and undesirable (e.g. I can remember “playing sick” to get out of something).  
Internal consistency has been found to be adequate, with Cronbach’s alpha values 
ranging from .70-.77 (Crino, Svoboda, Rubenfeld, & White, 1983).  Test-retest reliability 
over a period of a month was found to be high (r = .86) (Crino et al., 1983).  Tests of 
validity have demonstrated that persons who score highly on this measure of social 
desirability have difficulty admitting to stigmatized behaviors including cocaine use 
(Johnson & Fendrich, 2002).  Moreover, positive correlations have been found between 
social desirability and positive self-evaluations.   
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Lab Measures 
 
Expectancy and Motivation  
In research on placebo mechanisms, expectancy is most often assessed before the 
presentation of placebo with one item which assesses the degree to which the participant 
believes the treatment will benefit them (e.g., Hyland & Whalley, 2007).  Motivation, 
although not as widely studied, is often assessed similarly (e.g., Vase, Robinson, Verne, 
& Price, 2005).  The method used in the current study to assess expectancy and 
motivation was similar, although ten items were used to assess each construct using a 7-
point Likert scale (see Appendix B).  These items were face valid measures of 
expectancy (e.g. I think that the pheromones will influence my attractiveness ratings) and 
motivation (e.g. I hope that I find the scent of my matches to be most pleasing) and the 
original items were found to have high reliability in the pilot study (alpha values greater 
than .80).  The ten items were averaged to provide an overall assessment of motivation 
and expectancy.  The purpose of these measures was to serve as a manipulation check.  
 
Desirability  
Students rated their feelings of attraction on the following bi-polar dimensions: 
unattractive-attractive, unsexy-sexy, un-arousing-arousing (see Appendix B).  They 
indicated their feelings of attraction by marking on a continuum.  Following the study, 
these marks were translated to numerical data (e.g. unattractive- 1 to attractive- 9).  The 
sum of the numerical ratings of attractiveness, sexiness, and arousal was averaged to 
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obtain an overall rating of desirability for each of the four scents.2  Attraction, arousal, 
and sexiness are ideal outcome variables with which to assess placebo effects because 
these are sensations which are largely influenced by perception.  Participants must assess 
their feelings and physiological states in order to determine their level of attraction.  
Because these internal states are ripe with ambiguity, this task provides an excellent 
means for placebo responses to develop. 
 
Measures of Attention 
Task diligence was assessed in two ways: 1) the total time (in seconds) 
participants spent on the scent rating task and 2) the total number of times that the 
participant smelled the scents.  In order to provide the most unobtrusive means of 
assessment, time was measured using a stopwatch on a cell phone, which was placed on 
the experimenter’s lap.  The time began once students were instructed to start the rating 
task and ended when students completed their ratings for all four samples and indicated 
to the experimenter that they were finished with the task.  The number of times 
participants smelled each sample was recorded by the experimenter, who was seated 
across from the participant.  Distinct sniffs were identified when participants removed the 
mask at least 2 inches from the face and reapplied the mask to make another assessment.  
                                                 
2 Cronbach’s alpha values over .85 for each scent rating provided support for the use of an overall construct 
of ‘desirability’.   
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Placebo Response 
Placebo response was assessed as the overall desirability rating (average of 
arousal, attractiveness, and sexiness) of the selected scent and the variability, as assessed 
by standard deviation, in the overall ratings of the four scents.   Those who rated the scent 
to be more desirable displayed greater response to the placebo.  Moreover, as each scent 
sample is identical, students who reported greater differences among scents, as assessed 
by variability, demonstrated greater placebo response.  Other measures of variability 
including range and variance were analyzed, but did not change study results.  
 
Statistical Design and Power 
The current study has three main hypotheses.  First, that greater motivation would 
lead to greater attention, second, that attention would mediate the relationship between 
motivation and placebo response and third, that expectations would positively influence 
placebo response.  In order to test the first hypothesis, regression analyses (one for each 
measure of attention/diligence) were conducted in which the dummy-coded group 
variables motivation and expectancy were entered as predictors and the ‘time in seconds 
for task completion’ and ‘number of times smelled’ were entered as the dependent 
variables.  It was predicted that greater levels of motivation, but not expectancy, would 
lead to greater attention.  In order to test the second hypothesis, a regression test of 
mediation was used, which is described in greater detail in the results section.  Lastly, 
placebo response was regressed on the dummy-coded experimental expectancy group in 
order to test that hypothesis that expectancy would positively influence placebo 
outcomes.  The presence of interactions between expectancy and motivation would 
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provide further insight into the role of these two variables in producing placebo 
responses.   
 Given that effect sizes vary widely by setting, it is difficult to choose as estimated 
effect for the current study.  Studies which examine the mechanisms of placebo 
responding, as in the current study, have been found to have larger effect sizes, likely due 
to the careful consideration of factors which are known to increase effects (Price, Finniss, 
& Benedetti, 2008).  Thus, given a general range of effect sizes in experimental placebo 
studies of .51 to .95, a conservative estimate of effect size would be at the low end of this 
range of values (an effect size of about one half a standard deviation).  With a power of 
.80 and an effect size of .50, a total sample size of 75 is needed.    
 
Pilot Study 
Because the study utilized a new research design in examining placebo 
mechanisms, a pilot study was conducted to gauge the appropriateness of the study 
design for examining placebo mechanisms.  The pilot study consisted of a total sample of 
40 undergraduate students.  Regression analysis indicated that there was an effect for 
motivation, β = .43, t(37) = 2.88, p < .01, but not expectancy, β = .01, t(37) = .08, p < 
.93, on the dependent variable of placebo response, ‘best scent,’ or the desirability rating 
of the chosen scent.  There were no effects for either motivation, β = .24, t(37) = 1.50, p 
< .14, or expectancy, β = .16, t(37) = 1.02, p < .31, on the other primary dependent 
variable of placebo response, ‘variability of the scent ratings’(as assessed by standard 
deviation).  Motivation predicted task diligence as assessed by ‘number of times 
smelled,’ β = .50, t(37) = 3.51, p < .01, but not ‘total time smelled’, β = .17, t(37) = 1, p < 
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.32.  Expectancy did not predict either measure of task diligence.  Lastly, ANOVA 
analyses revealed no significant differences between experimental groups on the 
manipulation check expectancy measure, F(1, 38) = 8.5, p<.47, and motivation measure, 
F(1, 38) = 1.43, p<.26.   
Motivation influenced ‘best scent’ (measure of placebo response) and ‘number of 
times smelled’ (measure of diligence), but not the other study variables; expectancy 
influenced none of the study variables.  Although not all of the hypothesized effects were 
observed, it is possible that these effects were present, but were difficult to detect given 
the small sample size.  Support for this assertion can be found in a simple examination of 
means, which suggests small, but non-significant effects in hypothesized directions.  Of 
additional concern, the manipulation check suggested that none of the four experimental 
groups differed on levels of motivation and expectancy.  There are several potential 
reasons for the lack of significant findings on the manipulation check measure.  First, it is 
possible that the manipulation check was poorly designed and that groups did differ on 
levels of motivation and expectancy, but these differences were not detected by the 
measures.  Support for this assertion can be found in the observed effects for motivation 
consistent with the hypotheses, although the manipulation check suggested motivation 
had not been manipulated.  Second, it is possible that expectancy and motivation were not 
manipulated and that the effects that were observed are not a good test of the study’s 
hypotheses.  
The current study design was altered in several ways in order to address these 
concerns.  First, the manipulations were made stronger.  More detail was added to the 
scripts for each experimental group, with the intention of increasing the impact of the 
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expectancy and motivation manipulations.  In addition, participants were asked to answer 
the following question after the prompt in order to help ensure subjects attended to the 
information in the prompts: “Do you see how pheromones do/do not influence 
attraction?” Next, the design of the dating component of the study was altered so that 
subjects believed they would have the opportunity to complete a second phase of the 
study with their match, rather than have the opportunity to contact the match after the 
completion of the study.  This change was made after several subjects (both male and 
female) indicated that contacting their match after the conclusion of the study would be 
‘weird.’  Giving subjects the opportunity to meet their matches under the guise of 
research study involvement seemed to eliminate much of their apprehension.  Next, 
participants in all four experimental groups were told, prior to engaging in the scent 
rating task, that they were to respond honestly and if they didn’t perceive differences 
among smells, it was o.k. to indicate this in their ratings.  This statement was added to the 
prompt after the follow-up interviews revealed that some students made extreme ratings 
not because these ratings reflected their true response to the scents, but because they 
wanted to be cooperative.  Thus, the intent of this statement was to reduce the effect of 
demand characteristics such as desire to please the experimenter and social desirability, 
effects which were not within the domain of the current study.  Lastly, the manipulation 
check measure was altered to include more items which assessed a broader domain of 
expectancy and motivation.  The measure was increased from 6 items to 20 items.  These 
changes are all described in greater detail in the ‘Current Study’ and ‘Measures’ sections.   
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RESULTS 
 
Sample Description 
 One hundred fifty four participants completed the study.  Two participants were 
dropped from the analysis because they reported being involved in an exclusive 
relationship at the time of the study.  The final sample of 152 participants ranged in age 
from 18 to 51 with a mean age of 22 (SD = 6) (see Table 2).  Seventy-one percent of the 
sample was female; the majority of the subjects reported their ethnicity as Caucasian 
(69%), followed by African American (13%), Asian American (7%), Hispanic American 
(3%), and Other (8%).  Ninety-four percent reported a heterosexual orientation, followed 
by homosexual (3%) and bisexual (3%).  Year in school for the sample was as follows: 
freshman (47%), sophomore (28%), junior (17%), senior (5%), and other (3%).   Of the 
152 participants in the total sample, 38 were assigned to group 1, 39 to group 2, 38 to 
group 3, and 37 to group 4.  
 
Study Variables 
Mean, standard deviation, and dispersion statistics for all study variables are listed 
in Table 3.   Skewness and kurtosis statistics near zero indicate symmetric and normally 
distributed data.  General rules of thumb for interpreting skewness and kurtosis statistics 
suggest that statistics which fall outside the range -1 to 1 or +/- twice the standard error of 
each statistic indicate significant skewness and kurtosis (Tabachnick & Fidell, 1996).  
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Dispersion statistics for primary study variables are as follows: number of times smelled 
(skewness = 1.53, kurtosis = 2.72), time smelled (skewness = 1.13, kurtosis = .80), 
variability of ratings (skewness = .41, kurtosis = -.37), best scent (skewness = -.69, 
kurtosis = 1.57).  Both tests of significance yielded similar results, with the variable 
‘number of times smelled’ displaying high levels of skewness and kurtosis.  ‘Time 
smelled’ was characterized by significant positive skewness and ‘best scent’ displayed 
significant positive kurtosis.  Positive kurtosis indicates values more closely clustered 
around the mean whereas negative kurtosis indicates greater dispersion, relative to a 
normal distribution.  Positive and negative skewness indicate an extended right and left 
tail, respectively.  Logarithmic transformations successfully corrected data distributions 
problems, but did not affect primary results or data interpretation.  Results reported below 
are based on non-transformed data.     
  
Manipulation Check 
A 20-item questionnaire including 10 self-report expectancy items and 10 self-
report motivation items was used to assess the effectiveness of the manipulation.  
Cronbach’s alpha values for the 10 item expectancy and motivation measures were .82 
and .80, respectively.  Mean and standard deviation values are listed in Table 3.  It was 
expected that both high motivation groups would score higher on the motivation measure 
than the two low motivation groups and similarly, that the two high expectancy groups 
would score higher on the expectancy measure than the two low expectancy groups.  
Some, but not all, of these expectations were observed.  One-way ANOVA tests were 
significant for group differences on the expectancy, F(1, 152) = 10.7, p<.01, but not 
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motivation measure, F(1, 152) = 1.52, p<.21.  Post-hoc group comparisons revealed that 
the low-motivation, low-expectancy group was significantly lower on the self-report 
measure of motivation than the high-motivation, high-expectancy group; no other 
differences on the motivation measure were found between groups (see table 4 and figure 
3).  On the 10-item measure of expectancy, the low-expectancy, low-motivation group 
was significantly lower than both of the high expectancy groups and, unexpectedly, was 
also lower on the measure of expectancy than the low-expectancy, high-motivation group 
(see table 5 and figure 2).    
Both self-report measures predicted all primary study variables.  Those scoring 
higher on the expectancy measure also displayed greater task diligence, as assessed by 
time smelled, β = .23, t(150) = 2.85, p < .01, and number of time smelled, β = .20, t(150) 
= 2.49, p < .01, and placebo response, as assessed by best scent, β = .22, t(150) = 2.68, p 
< .01, and variability in ratings, β = .17, t(150) = 2.11, p < .04.  Similarly, the motivation 
measure predicted all variables: time smelled, β = .29, t(150) = 3.73, p < .01, number of 
times smelled, β = .21, t(150) = 2.62, p < .01, best scent, β = .33, t(150) = 4.22, p < .01, 
and variability in ratings, β = .21, t(150) = 2.66, p < .01.  When included as a predictor, 
along with the self-report measures of expectancy and motivation and the expectancy 
experimental group, the motivation experimental group remained a significant predictor 
of all primary study variables, best scent, β = .18, t(147) = 2.16, p < .03,  variability of 
scent ratings, β = .17, t(147) = 2.04, p < .04, number of smells, β = .25, t(147) = 3.01, p < 
.01, and time smelled, β = .22, t(147) = 2.68, p < .01.  Moreover, when all four variables 
were included as predictors in simultaneous regression, self-reported motivation and 
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manipulated motivation were predictive of both measures of task diligence and only 
manipulated motivation was predictive of placebo response, as assessed by best 
scent, β = .53, t(147) = 2.16, p < .03, and variability in scent ratings, β = .172, t(147) = 
2.04, p < .04.  Thus, statistically significant unique variance could be attributed to self-
reported motivation and manipulated motivation in the prediction of mediators and only 
to manipulated motivation in predicting placebo response.   
 
Analysis of Hypothesized Effects 
 The current study has three main hypotheses.  First, that greater motivation would 
lead to greater attention, second, that attention would mediate the relationship between 
motivation and placebo response and third, that expectations would positively influence 
placebo response.  In order to test the first hypothesis, which predicted motivation would 
lead to greater attention/task diligence, regression analyses were conducted for each 
measure of attention, number of times smelled and total time smelled (in seconds), with 
both the motivation and expectancy experimental groups entered as predictors.  The 
overall regression equations were significant for number of times smelled, F(2, 149) = 
5.09, p<.01,  and total time smelled, F(2, 149) = 4.94, p<.01 (see Table 6).  Motivation 
significantly influenced number of times smelled, β = .25, t(149) = 3.19, p < .01, and 
total time smelled, β = .24, t(149) = 2.99, p < .01.  Thus, students in the high motivation 
conditions displayed greater task diligence and the first hypothesis was supported.  
Expectancy did not influence either the number of times smelled, β = -.03, t(149) = -.33, 
p < .74,  or the total time smelled, β = .08, t(149) = .97, p < .34.  
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The second hypothesis which posited that attention would mediate the 
relationship between motivation and placebo response was examined through a 
regression test of mediation.  In order to demonstrate mediation through this test, it must 
first be demonstrated that the IV predicts both the mediator and DV and that the mediator 
predictors the DV, and secondly, when the mediator is added to the overall regression 
equation, the influence of the IV on the DV is decreased (Baron & Kenny, 1986).  
Consistent with these criteria, it was demonstrated that motivation predicted both 
measures of placebo response, variability of ratings, β = .21, t(150) = 2.65, p < .01, and 
best scent, β = .23, t(150) = 2.86, p < .01, and both measures of task diligence, number of 
times smelled, β = .25, t(150) = 3.19, p < .01, and total time smelled, β = .24, t(150) = 
2.99, p < .01 (see Table 6).  Secondly, number of times smelled predicted both measures 
of placebo response, variability of scent ratings, β = .20, t(150) = 2.51, p < .01, and best 
scent, β = .33, t(150) = 4.21, p < .001.  Similarly, total time smelled predicted both 
variability in scent ratings, β = .24, t(150) = 3.03, p < .01, and best scent, β = .44, t(150) 
= 5.97, p < .001.  Thus, the predictor variable (motivation) predicted both measures of the 
outcome variable (placebo response) and both measures of the mediator (task diligence).  
In addition, the mediator variable (task diligence) predicted both measures of the 
outcome variable (placebo response).  
Furthermore, the mediation was found to be significant for most paths.  Adding 
the mediator variable ‘time smelled’ as a predictor reduced the effect of motivation on 
placebo response, as measured by ‘best scent.’  The overall regression equation was 
significant, F(2,149) = 19.57, p<.01, and the standardized regression coefficient for 
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motivation dropped from .23 (β = .23, t(150) = 2.85, p < .01) to .13 (β = .37, t(149) = 
1.74, p < .08).  Sobel’s test statistic, which assesses the significance of the change in Beta 
value, indicated that this drop was significant (Sobel statistic = 6.38, p<.01).  Similar 
results were found for the regression of ‘best scent’ on ‘number of times smelled’ and 
motivation, F(2,149) = 10.98, p<.01.  The addition of the mediator reduced the 
standardized regression coefficient for motivation from .23 (β = .23, t(150) = 2.85, p < 
.01)  to .16 (β = .16, t(149) = 1.96, p < .06), which was found to be significant (Sobel’s 
statistic = 2.69, p<.01).  Lastly, adding the mediator variable ‘time smelled’ as a predictor 
reduced the effect of motivation on placebo response, as measured by ‘variability in 
ratings.’  The overall regression equation was significant, F(2,149) = 6.75, p<.01, and the 
standardized regression coefficient for motivation dropped from .21 (β = .21, t(150) = 
2.65, p < .01) to .16 (β = .16, t(149) = 2.03, p < .04).  Sobel’s test statistic indicated that 
this drop was significant (Sobel statistic = 1.98, p<.05).  Adding the mediator variable 
‘number smelled’ as a predictor reduced the effect of motivation on placebo response, as 
measured by ‘variability in scent ratings’, but this drop was not found to be significant 
(Sobel’s statistic = 1.70, p<.09).  Overall, the results suggest partial mediation; the effect 
of motivation on placebo response was partially mediated by attention/task diligence.   
 Lastly, the third hypothesis, which predicted that expectancy would influence the 
level of placebo response, was not supported.  The regression of placebo response, as 
assessed by ‘best scent’ on the experimental groups of expectancy and motivation was 
significant, F(2,149) = 4.06, p<.02, but expectancy was not found to be a significant 
predictor, β = -.01, t(149) = -.11, p < .91 (see Table 6).  Similarly, the regression of 
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placebo response, as assessed by ‘variability of scent ratings’, on the experimental groups 
of expectancy and motivation was significant, F(2,149) = 4.15, p<.02, but expectancy 
was not found to be a significant predictor, β = .09, t(149) = -1.13, p < .26.   
In conclusion, regression tests of mediation indicated that ‘number of times 
smelled’ and ‘total time smelled’ mediated the relationship between motivation and the 
outcome variables ‘best scent’ and ‘variability in scent ratings’ (although the mediation 
for variability was only significant for the mediator ‘time smelled’ and not ‘number 
smelled’).  Thus, motivation led to greater task diligence as measured by greater time 
engaging in the scent rating task and greater number of ratings made.  Task diligence, in 
turn, led to greater placebo response as measured by more attractive ratings of the chosen 
scent and variability in the scent ratings.  Inconsistent with hypothesized effects, 
expectancy did not influence placebo response.    
 
Secondary Measures 
 All subjects completed a survey which consisted of the Big Five Inventory (BFI), 
a relationship attitudes scale, the LOT-R, and a measure of social desirability.  Although 
the main purpose of this survey was to increase the strength of the motivation 
manipulation, the survey results also provided interesting data for follow-up analyses.  
Examining the five BFI subscales (extraversion, agreeableness, conscientiousness, 
neuroticism, openness), significant correlations were found between agreeableness and 
variability of scent ratings, r(150) = -.21, p<.01, openness and total time smelled r(150) 
=.17, p<.04, and openness and best scent, r(150) =.17, p<.04 (see table 7).  No other 
significant correlations were found between BFI subscales and the mediating variables of 
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‘time smelled’ and ‘number of times smelled’ or the primary dependent variables of ‘best 
scent’ or ‘variability of scent ratings.’  Social desirability was found to be negatively 
related to both of the primary outcome variables, best scent r(150) = -.22, p< .02, and 
variability of scent rating r(150) = -.23, p<.01.  Optimism, as assessed by the LOT-R, 
was not found to be related to any of the four primary study variables (total time smelled, 
number of times smelled, best scent, and variability of scent ratings).  Moreover, when 
controlling for social desirability and openness, the motivation experimental group 
remained a significant predictor of both primary dependent variables, best scent, β = .17, 
t(149) = 2.18, p < .03, and variability of scent ratings, β = .20, t(149) = 2.44, p < .02.   
 
Experimenter Effects 
There were a total of five experimenters involved in data collection.  One-way 
ANOVA analyses revealed no differences by experimenter on any of the primary study 
variables: best scent F(1,150) =.54, p<.75, variability of scent ratings, F(1, 150) =.44, 
p<.82, time smelled, F(1,150) =.54, p<.75, and number of times smelled, F(1,150) = 
1.48, p<.20.   
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DISCUSSION 
 
Motivation has not been widely studied as a mechanism of change in placebo, 
with most research focusing on the role of expectancy in placebo outcomes.  Although 
motivation is not often measured or manipulated, it is reasonable to assume that placebo 
effects observed in traditional placebo research may represent motivational influences in 
addition to expectancy effects.  It follows that when motivation is manipulated and 
measured, as in the current study, the strong effects of motivation in placebo become 
apparent.  Current findings suggest that motivation effects have a greater influence on 
placebo than previously thought and may even overshadow expectancy when motivation 
is maximized.    
 The current study identifies an important mediating variable in placebo and 
expands on previous findings by clearly outlining a model of change.  Moreover, the 
findings suggest that motivation-attention models are a meaningful way to conceptualize 
placebo change.  Those students more highly motivated to respond to placebo were more 
involved in assessing the placebo substance and as a result, responded more highly to the 
placebo.  This process is consistent with findings in perception literature, which highlight 
the important role that motivation plays in forming perceptions of various affective states 
(Xing & Isaacowitz, 2006), social judgments (Erber & Fiske, 1984), and visual stimuli 
(Balcetis & Dunning, 2007).   
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The results of this study are consistent with a cognitive or motivational 
interpretation of placebo.  As previously discussed, placebo responses are believed to be 
produced through two pathways, one within awareness, consistent with the expectancy 
model, and one outside of awareness, which is more consistent with a conditioning 
model.  This distinction is important, as different mechanisms are believed to underlie 
each model.  Research on the psychological processes involved in placebo analgesia has 
demonstrated that activation of opioid and dopamine systems in areas such as the nucleus 
accumbens may underlie changes in self-reported pain perception (e.g., Scott, Stohler, 
Egnatuk, Wang, Koeppe, & Zubieta, 2007).  Other research has demonstrated that 
alternative pathways may also underlie placebo responses.  For example, both expectancy 
and conditioning placebo manipulations can produce lowered pain perception, but only 
conditioning manipulations have been found to impact hormone secretion, a marker of 
pain (e.g., Benedetti, Pollo, Lopiano, Lanotte, Vighetti, & Rainero, 2003).  
Neurophysiological research on pain perception has also identified distinct pathways. 
Sensory neurons appear to communicate the affective component and physical pain 
component to the brain through different pathways, suggesting that research on 
motivational-expectancy influences on placebo may be acting on the former, rather than 
latter, pathway (Lumkin, Marshall, & Nelson, 2010).  It is believed that these pathways 
do not act in isolation, but rather interact and share information, ultimately influencing a 
person’s overall subjective experience of sensory input.   
The failure to take into account these different pathways can lead to an 
incomplete understanding of clinical treatment effects.  A recent study on placebo effects 
in irritable bowel syndrome treatment found that even when assignment to the placebo 
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group was clearly communicated to participants, presumably reducing treatment 
expectancies, the placebo treatment effect equaled that of the regular treatment group 
(Kaptchuk, Friedlander, Kelley, Sanchez, Kokkotou, et al., 2010).  The authors concluded 
that the simple act of engaging in a medical ritual may be helpful to some patients, 
regardless of their expectation of benefit.  Examining these findings within the context of 
placebo theory, it is possible another variable, such as motivation, influenced responding 
or that patients had been conditioned to respond to medical settings, consistent with a 
conditioning theory of placebo.  As suggested in research on physiological mechanisms 
of placebo, expectancy, motivation, and conditioning theories imply different pathways 
which are believed to act on different biological systems.  This study demonstrates the 
importance of considering the multiple pathways of placebo and suggests that even when 
one pathway is not acted on, placebo responses may be produced through another.   
Examining a motivation-attention model of placebo in relation to physiological 
models of placebo provides a broader framework through which to view current findings.  
This study examined the process of placebo change at the perceptual and behavioral 
level, specifically by examining changes in motivation, behavioral markers of attentional 
bias, and perception of smell.  Although little research exists on the role of placebo in 
olfactory sensation, the physiological underpinnings of this process may reasonably be 
expected to occur in areas of the brain which are more readily associated with reward, 
motivation, and expectations, as found in other research on placebo mechanisms (e.g., 
Scott, Stohler, Egnatuk, Wang, Koeppe, & Zubieta, 2007).  Thus, manipulating 
motivation may alter the affective component of smell, altering an individual’s overall 
experience of the scent.  The current study provides a possible explanation for one 
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component of the placebo process as it relates to psychological variables, and highlights 
that even within a broader context of neurophysiological systems, factors such as 
motivation and attentional bias play an important role in one’s perceptual experience and 
placebo responding. 
 
Methodological Shortcomings 
One concern with the study design is whether or not the variables were 
manipulated as intended.  Although results of the manipulation check suggested that 
many groups did not differ on levels of expectancy and motivation, the differences that 
were observed were consistent with expectations.  The low-motivation, low-expectancy 
group was significantly lower on the self-report measure of motivation than the high-
motivation, high-expectancy group.  The low-expectancy, low-motivation group was 
significantly lower than both of the high expectancy groups on the measure of 
expectancy.  One possible interpretation of these findings is that the manipulation check 
measure is a valid measure of the constructs of interest and that the lack of significant 
findings demonstrates a failure to manipulate motivation and expectancy.  It is also 
possible that motivation or expectancy, or both, were in fact manipulated but that this 
measure did not adequately assess these constructs.  Examining the study results, there is 
more evidence for the assertion that motivation was manipulated, but poorly measured, 
than there is regarding the manipulation of expectancy. 
There were strong effects for the motivation variable, which were consistent with 
hypothesized effects, providing some support for the assertion that motivation was 
manipulated, but not well-detected by the motivation measure.  The analysis of the 
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expectancy measure is less clear.  There were differences between groups on the measure 
of expectancy which were consistent with expectations, but only a few of these group 
comparisons rose to significance.  Moreover, the expectancy manipulation did not 
influence study variables.  Thus, it may be that expectancy was not manipulated or if it 
was manipulated, it did not influence placebo outcomes.  Due to the null findings for the 
expectancy group variable and failure of the manipulation check to demonstrate 
manipulation of expectancy, caution should be used when interpreting the results.  The 
current study’s findings are more informative in examining the role of motivation in 
placebo effects. 
Although scores on the self-report expectancy and motivation measures did not 
correspond exactly to manipulated levels of each variable, both measures predicted task 
diligence and placebo response and were moderately correlated, r(152) = .36, p<.01.  It is 
possible that these self-report measures indicate individual differences in expectancy and 
motivation, beyond the experimental manipulation.  Data analysis revealed that even 
when including the self-report measures of motivation and expectancy as predictors in 
regression, manipulated motivation remained a strong and significant predictor of all 
study variables.  A second interpretation of this data is that the self-report expectancy and 
motivation measures tapped constructs of study involvement, interest, or demand 
characteristics and that students high on these measures were more engaged in all stages 
of the study, regardless of the experimental manipulation.  These constructs are certainly 
within the realm of placebo and some researchers have conceptualized placebo as exactly 
this (e.g., Geers, Kosbab, Helfer, Weiland, & Wellman, 2007).  However, given the 
current study’s interest in placebo mechanisms, the goal of outcome assessment was to 
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measure experienced internal states, while minimizing demand characteristics (although 
it is easy to appreciate the difficulty in disentangling the two).   
Further complicating assessment, motivation and expectancy were moderately 
correlated and may have had bi-directional influences, in that the manipulation of one 
variable altered levels of the other.  Consistent with this assertion, the low-low group 
ranked lowest and the high-high group ranked highest, on both measures of self-reported 
expectancy and motivation.  These differences did not all rise to levels of significance, 
but a trend clearly indicated that groups where both expectancy and motivation were 
maximized or minimized resulted in the greatest change in each variable.  More moderate 
effects were observed in mixed (high-low, low-high) groups, suggesting that 
maximization of one variable was more difficult in groups where the other was 
minimized, and vice versa.  These findings lend some support to the assertion that 
expectancy and motivation may have had bi-directional influences, thus complicating 
data interpretation by making it more difficult to examine the individual effects of each.   
 
Secondary Measures 
Interestingly, social desirability was found to be negatively related to both of the 
primary dependent variables, best scent and variability of scent ratings.  This is somewhat 
contradictory to other research studies which have found placebo effects to be related 
positively to social desirability (e.g., Gelfand, Gelfand, & Rardin, 1965) although, as 
previously discussed, the consistency of such findings is debated.  Conversely, two study 
variables, ‘total time smelled’ (measure of diligence) and ‘best scent’ (measure of 
placebo response) were found to be positively related to the personality variable 
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‘openness.’ An examination of the constructs of social desirability and openness within 
the context of the current study design may help to explain these findings.   
Social desirability is meant to capture a general concern with how one presents 
oneself to others and is associated with behaviors such as unwillingness to report 
psychological distress (Johnson & Fendrich, 2002).  The trait of openness to experience 
as assessed by the BFI, captures characteristics such as imagination, insight, and 
intellectual curiosity; those who score low on this scale tend to be more traditional in 
their outlook and behavior (Soto & John, 2009).  In this study, students were asked to rate 
the pheromone samples of members of the opposite sex by how arousing, attractive, and 
sexy they found the samples to be.  This task could be perceived as potentially 
embarrassing and anxiety provoking, especially by those people who are less comfortable 
expressing sexuality and attraction.  Thus, it may have been difficult for some people to 
endorse feelings of arousal and attraction, especially in the presence of a researcher.  It 
may be the case that social desirability in this study manifested not a general desire to 
please the experimenter, but as a hesitation to express potentially embarrassing feelings 
of sexual arousal.  Those scoring high on openness, in contrast, would have presumably 
been more open to engaging in the scent rating task and reporting feelings of arousal, 
consistent with the results showing a positive correlation between openness and placebo 
response.  Although this is certainly only one interpretation of the results, it does offer a 
compelling explanation for the observed pattern of findings.  
 As mentioned above, these findings are inconsistent with previous studies which 
found a positive relation between social desirability and placebo (e.g., Gelfand, Gelfand, 
& Rardin, 1965) and lend support to the current understanding of placebo as not reliably 
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related to personality factors.  The findings of this study suggest that one possible 
explanation for the lack of consistency may be that personality factors manifest in 
different ways depending on the nature of the placebo treatment and other situational 
factors.  For example, expressing pain relief (e.g., Gelfand, Gelfand, & Rardin, 1965) 
may be more agreeable to those high on the trait of social desirability, than endorsing 
feelings of sexual arousal.  Thus, the effect of personality on placebo may be context 
specific; only when there is a match between situational factors and personality style will 
personality be a predictor of placebo responding.   
 
Implications 
The results of this study do not discount the role of expectancy, but rather 
underscore the important role of motivation in producing placebo effects.  Although 
expectancy did not influence study variables, motivation did lead to greater task 
diligence, which, in turn, led to higher placebo responding.  Students in the high 
motivation group spent more time on the rating task, smelled the samples a greater 
number of times, and as a result, rated their chosen sample to be more pleasing and had 
greater overall variability in the sample ratings.  Current findings suggest a possible 
mechanism of change in placebo effects and have important implications for the study of 
placebo.   
Understanding the mechanisms by which placebo is produced has implications in 
many clinical settings, where placebo is believed to play an important role in producing 
treatment effects.  If greater attention to signs of improvement is the process through 
which placebo is produced, clinicians may be able to increase treatment effects not only 
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by increasing motivation to improve, but also by encouraging patients to monitor 
themselves for signs of improvement.  Intervening at the level of this mediating variable 
may help clinicians to maximize placebo, thereby increasing treatment effects.  
Moreover, an understanding of psychological variables in placebo helps to provide a 
more complete picture of an individual’s overall perceptual experience, which has 
relevance to areas of research including pain management, psychopharmacological 
treatment of mental disorders, and smoking cessation, to name a few. 
 
Suggestions for Future Research 
Future research should seek to further clarify the relationship of expectancy and 
motivation to placebo outcomes and continue to examine mediating factors such as 
attention.  Efforts should also be made to more carefully design studies which maximally 
manipulate expectancy and motivation.  The current study utilized a novel approach to 
the study of placebo, which lent itself well to the study of mechanisms, as overt behaviors 
related to scent assessment could be observed.  Moreover, the task appeared to be very 
engaging to participants, an observation which was supported in informal follow-up 
interviews with participants and by the large effects for the motivation manipulation.  
This would likely be a good paradigm for the future study of placebo mechanisms, 
although efforts should be made to address the less than optimal manipulation of 
expectancy.  New methods to manipulate expectations should be explored which don’t 
rely on the traditional verbal inducement of expectations common to placebo research.   
Lastly, researchers should continue to examine the multiple pathways of placebo, 
their potential interactions, and manifestations at the psychological, behavioral, and 
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physiological level.  Motivation-attention models appear to be a useful paradigm through 
which to study placebo and future study of placebo mechanisms can be further informed 
by models of perception and motivation.  This will provide not only a more 
comprehensive model of placebo, but also a better understanding of the factors and 
processes that shape overall perceptual and sensory experience.  
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Table 1. Current Models of Placebo Responding  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Model Model Overview Important 
Elements 
Lundh’s (1987)  
Expectancy 
Model  
Expectancies lead to greater 
attention, which results in evidence 
of the placebo’s effectiveness. This 
evidence strengthens future 
responding to placebo. 
Expectancy, 
Attention 
Goal-
Activation 
Model 
Placebo effects are produced when a 
person holds expectancies which are 
compatible with motivation.   
Expectancy, 
Motivation 
 
Desire-
Expectancy 
Model 
The desire (motivation) to respond 
to placebo can be likened to 
approach and avoidance goals.  
Avoidance goals produce negative 
affect.  Motivation and expectancies 
lead to greater attention which 
results in evidence of the placebo’s 
effectiveness, reducing negative 
affect.   
Expectancy, 
Attention, 
Motivation  
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Table 2. Demographic Variables (N = 152) 
Variable Mean or number (SD or %) 
Age 22 (6) 
   
Gender   
    Female 108 (71%) 
    Male 44 (29%) 
   
Race   
    Caucasian 105 (69%) 
    African American 20 (13%) 
    Asian American 11 (7%) 
    Hispanic American 4 (3%) 
    Other 12 (8%) 
   
Year in school   
    Freshman 71 (47%) 
    Sophomore 42 (28%) 
    Junior 26 (17%) 
    Senior 8 (5%) 
    Other 5 (3%) 
   
Sexual Orientation    
    Heterosexual 143 (94%) 
    Bisexual  5 (3%) 
    Homosexual 4 (3%) 
 
 
 
 
 
 
 
72 
 
 
 
 
 
 
 
 
Table 3. Mean, Standard Deviation, and Dispersion Statistics for Study Variables  
Primary Study Variables 
 Mean Standard 
Deviation 
Skewness Kurtosis 
Expectancy 3.6 .56 -.69 .82 
Motivation 2.8 5 .16 -.51 
# sniffs 12 7.9 1.52 
(SE*=.20) 
2.71 
(SE=.39) 
Time smelled  156 79 1.13 
(SE=.20) 
.80 
(SE=.39) 
Best Scent 6.1 1.4 -.69 
(SE=.20) 
1.57 
(SE=.39) 
Variability Ratings 1.1 .80 .41 
(SE=.20) 
-.37 
(SE=.39) 
Secondary Study Variables  
 Mean Standard 
Deviation 
Skewness Kurtosis 
LOT 3.6 .72 -.70 .25 
Social Desirability  16.7 5.1 -.11 -.32 
Extraversion  29 6.1 -.53 -.35 
Agreeableness 35.9 5.0 -.39 -.24 
Conscientiousness 34.1 5.3 -.69 1.11 
Neuroticism 22.4 6.3 .19 -.64 
Openness  36.4 6.3 -.08 -.35 
* Standard error of skewness and kurtosis 
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Table 4. ANOVA Post-Hoc Results of Mean 
Difference Comparisons for the Four Experimental 
Groups on the Self-Reported Motivation Measure 
 Group 1* Group 2 Group 3 
Group 1    
Group 2 .15, p<.18 
(Group 1-2) 
  
Group 3 .01, p<.98 
(Group 1-3) 
-.15, p<.18 
(Group 2-3) 
 
Group 4 -.08, p<.47 
(Group 1-4) 
-.23, p<.04 
(Group 2-4) 
-.08, p<.49 
(Group 3-4) 
    
*Group 1= Hi Motivation, Lo Expectancy (n=38) 
  Group 2= Lo Motivation, Lo Expectancy (n=39) 
  Group 3= Lo Motivation, Hi Expectancy (n=38) 
  Group 4= Hi Motivation, Hi Expectancy (n=37) 
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Table 5. ANOVA Post-Hoc Results of Mean 
Difference Comparisons for the Four Experimental 
Groups on the Self-Reported Expectancy Measure 
 Group 1* Group 2 Group 3 
Group 1    
Group 2 .55, p<.001 
(Group 1-2) 
  
Group 3 .07, p<.57 
(Group 1-3) 
-.48, p<.001 
(Group 2-3) 
 
Group 4 -.04, p<.77 
(Group 1-4) 
-.59, p<.001 
(Group 2-4) 
-.10, p<.39 
(Group 3-4) 
    
*Group 1= Hi Motivation, Lo Expectancy 
  Group 2= Lo Motivation, Lo Expectancy 
  Group 3= Lo Motivation, Hi Expectancy 
  Group 4= Hi Motivation, Hi Expectancy  
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Table 6. F, t, and Beta values for Regression of Primary Study Values on Motivation 
and Expectancy Experimental Groups 
 Best Scent Variability 
Scent 
Number 
Smells 
Time Smelled 
F-value, regression 
onto Motivation 
and Expectancy 
F(2, 151) = 4.06, 
p<.02 
F(2, 151) = 4.14, 
p<.02 
F(2, 151) = 5.10, 
p<.01 
F(2, 151) = 4.94, 
p<.01 
β and t-value for 
Motivation 
β = .23, t(151) = 
2.85, p < .01 
β = .21, t(151) = 
2.64, p < .01 
β = .25, t(151) = 
3.18, p < .01 
β = .23, t(151) = 
2.98, p < .01 
β and t-value for 
Expectancy 
β = -.01, t(151) = 
-.11, p < .91 
β = .09, t(151) = 
1.12, p < .26 
β = -.03, t(151) = 
-.33, p < .74 
β = .08, t(151) = 
.97, p < .33 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7. Correlations Between Secondary Measures of the BFI, LOT-R, and Social Desirability Scale with Primary Study 
Variables 
  
 Number 
Smelled 
Total 
Time 
Smelled 
Best 
Scent 
Variabil-
ity of 
Scents 
Extra-
version 
Agreeable
-ness 
Conscien-
tiousness 
Neuro-
ticism 
Openness Optimism 
(LOT-R) 
Social 
Desirabil-
ity  
Number Smelled 1 
 
          
Total Time 
Smelled 
.70** 
(p<.01) 
1          
Best Scent .33** 
(p<.01) 
.44 ** 
(p<.01) 
1         
Variability of 
Scents 
.20** 
(p<.01) 
.24** 
(p<.01) 
.61** 
(p<.01) 
1        
Extraversion 
(BFI) 
-.02 
(p<.80) 
-.01  
(p<.95) 
.06 
(p<.45) 
.13 
(p<.12) 
1       
Agreeableness 
(BFI) 
.05 
 (p<.52) 
-.05 
(p<.53) 
-.05 
(p<.57) 
-.21** 
(p<.01) 
.15  
(p<.07) 
1      
Conscientiousnes
s (BFI) 
-.07 
(p<.39) 
-.10 
(p<.23) 
-.10 
(p<.21) 
-.06 
(p<.49) 
.19*  
(p<.02)  
.34** 
(p<.01) 
1     
Neuroticism 
(BFI) 
.01  
(p<.88) 
0 
(p<.99) 
0 
(p<.99) 
-.05 
(p<.55) 
-.42** 
(p<.01) 
-.26** 
(p<.01) 
-.18*  
(p<.03) 
1    
Openness (BFI) .04  
(p<.62) 
.17* 
(p<.04) 
.17* 
(p<.04) 
.08 
(p<.31) 
.26** 
(p<.01) 
.12  
(p<.16) 
.09  
(p<.30) 
-.09  
(p<.30) 
1   
Optimism (LOT-
R) 
-.09 
(p<.27) 
-.12 
(p<.16) 
-.10 
(p<.22) 
-.06 
(p<.47) 
.38** 
(p<.01) 
.32** 
(p<.01) 
.33** 
 (p<.01) 
-.45** 
 (p<.01) 
.13 
(p<.12) 
1  
Social 
Desirability  
.01  
(p<.99) 
.03 
(p<.75) 
-.22* 
(p<.02) 
-.23** 
(p<.01)  
.13 
(p<.11) 
.42** 
(p<.01) 
.38** 
 (p<.01) 
-.38**  
(p<.01) 
.19*  
(p<.03) 
.30**  
(p<.01) 
1 
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Figure 1. Proposed Model of Placebo Responding 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expectancy 
Motivation 
Attention 
Placebo 
Response 
a 
c
  
   
b
  
   
Path a: Motivation increases attention to relevant stimuli 
Path b: Expectancy informs of the interpretation of these stimuli  
Path c: Altered attention results in placebo response 
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Figure 2. Expectancy Scores by Experimental Group 
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Figure 3. Motivation Score by Experimental Group  
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*error bars represent 95% confidence levels 
 
Figure 4. Rating of the Placebo Outcome ‘Best Scent’ by Experimental Group 
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*error bars represent 95% confidence levels 
 
Figure 5. Rating of the Placebo Outcome ‘Variability in Scent Rating’ by Experimental 
Group 
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Please answer the following questions: 
 
I am currently involved in a committed relationship    _____ Yes          _____ No  
 
What is your gender (check one)?   _____ Male          _____ Female 
 
What is your age?   _____ 
 
What best describes your racial or ethnic background (check one)? 
_____ 1. African American    _____ 2. Caucasian American    _____ 3. Native American  
_____ 4. Asian American      _____ 5.  Hispanic American     ________ 6. Other (please 
specify)  
 
What best describes your sexual orientation (check one)? 
_____ 1. Heterosexual    _____ 2. Homosexual    _____ 3. Bisexual    
 ___________ 4. Other (please specify)  
 
What year are you currently in school (check one)? 
_____ 1. Freshman    _____ 2. Sophomore    _____ 3. Junior    _____ 4. Senior 
_____ 5. Graduate    _____________ 6. Other (please specify)  
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The Big Five Personality Inventory  
Instructions: Here are a number of characteristics that may or may not apply to you.  For 
example, do you agree that you are someone who likes to spend time with others?  Please 
choose a number for each statement to indicate the extent to which you agree or disagree 
with this statement. 
How well do the following statements describe your personality? 
I see myself as 
someone who … 
Disagree 
strongly 
Disagree a 
little 
Neither agree 
nor disagree 
Agree a 
little 
Agree 
strongly 
Is talkative (1) (2) (3) (4) (5) 
Tends to find fault 
with others (1) (2) (3) (4) (5) 
Does a thorough job (1) (2) (3) (4) (5) 
Is depressed, blue (1) (2) (3) (4) (5) 
Is original, comes up 
with new ideas (1) (2) (3) (4) (5) 
Is reserved (1) (2) (3) (4) (5) 
Is helpful and 
unselfish with others (1) (2) (3) (4) (5) 
Can be somewhat 
careless (1) (2) (3) (4) (5) 
Is relaxed, handles 
stress well (1) (2) (3) (4) (5) 
Is curious about many 
different things (1) (2) (3) (4) (5) 
Is full of energy (1) (2) (3) (4) (5) 
Starts quarrels easily 
with others (1) (2) (3) (4) (5) 
Is a reliable worker (1) (2) (3) (4) (5) 
Can be tense (1) (2) (3) (4) (5) 
Is ingenious, a deep 
thinker (1) (2) (3) (4) (5) 
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I see myself as 
someone who … 
Disagree 
strongly 
Disagree a 
little 
Neither agree 
nor disagree 
Agree a 
little 
Agree 
strongly 
Generates a lot of 
enthusiasm (1) (2) (3) (4) (5) 
Has a forgiving nature (1) (2) (3) (4) (5) 
Tends to be 
disorganized (1) (2) (3) (4) (5) 
Worries a lot (1) (2) (3) (4) (5) 
Has an active 
imagination (1) (2) (3) (4) (5) 
Tends to be quiet (1) (2) (3) (4) (5) 
Is generally trusting (1) (2) (3) (4) (5) 
Tends to be lazy (1) (2) (3) (4) (5) 
Is emotionally stable, 
not easily upset (1) (2) (3) (4) (5) 
Is inventive (1) (2) (3) (4) (5) 
Has an assertive 
personality (1) (2) (3) (4) (5) 
Can be cold and aloof (1) (2) (3) (4) (5) 
Perseveres until the 
task is finished (1) (2) (3) (4) (5) 
Can be moody (1) (2) (3) (4) (5) 
Values artistic, 
aesthetic experiences (1) (2) (3) (4) (5) 
Is sometimes shy, 
inhibited (1) (2) (3) (4) (5) 
Is considerate and kind 
to almost everyone (1) (2) (3) (4) (5) 
Does things efficiently  (1) (2) (3) (4) (5) 
Remains calm in tense 
situations (1) (2) (3) (4) (5) 
86 
 
 
I see myself as 
someone who … 
Disagree 
strongly 
Disagree a 
little 
Neither agree 
nor disagree 
Agree a 
little 
Agree 
strongly 
Prefers work that is 
routine (1) (2) (3) (4) (5) 
Is outgoing, sociable (1) (2) (3) (4) (5) 
Is sometimes rude to 
others (1) (2) (3) (4) (5) 
Makes plans and 
follows through with 
them 
(1) (2) (3) (4) (5) 
Gets nervous easily  (1) (2) (3) (4) (5) 
Likes to reflect, play 
with ideas (1) (2) (3) (4) (5) 
Has few artistic 
interests (1) (2) (3) (4) (5) 
Likes to cooperate 
with others (1) (2) (3) (4) (5) 
Is easily distracted (1) (2) (3) (4) (5) 
Is sophisticated in art, 
music, or literature (1) (2) (3) (4) (5) 
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The Life Orientation Test- Revised 
 
Please indicate the extent to which you agree or disagree with each of the following 
items.  Try not to let your answer to one question influence your answers on other 
questions.  Also, try to be as accurate and honest as you can in answering.  There are no 
right or wrong answers.   
 
 Strongly Disagree Disagree 
Neither 
Agree nor 
Disagree 
Agree Strongly Agree 
In uncertain times, I 
usually expect the best. 
 
(1) (2) (3) (4) (5) 
It’s easy for me to relax. (1) (2) (3) (4) (5) 
If something can go 
wrong for me, it will. (1) (2) (3) (4) (5) 
I’m always optimistic 
about my future.  (1) (2) (3) (4) (5) 
I enjoy my friends a lot. (1) (2) (3) (4) (5) 
It’s important to me to 
keep busy. (1) (2) (3) (4) (5) 
I hardly ever expect 
things to go my way. (1) (2) (3) (4) (5) 
I don’t get upset too 
easily. (1) (2) (3) (4) (5) 
I rarely count on good 
things happening to me. (1) (2) (3) (4) (5) 
Overall, I expect more 
good things to happen 
to me than bad. 
(1) (2) (3) (4) (5) 
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Relationship Attitudes  
 
Indicate the degree to which you agree or disagree with the following statements. 
 
 
 Strongly Disagree Disagree 
Neither 
Agree nor 
Disagree 
Agree Strongly Agree 
A person can’t have a 
satisfactory and satisfying 
sex life without being in love 
with his partner. 
(1) (2) (3) (4) (5) 
Two people should not 
engage in sexual intercourse 
until they are married.   
(1) (2) (3) (4) (5) 
It makes me uncomfortable 
when other people express 
emotion. 
(1) (2) (3) (4) (5) 
It shows strength to express 
emotions openly. (1) (2) (3) (4) (5) 
For me, expressing 
emotions is an important 
part of settling disputes 
(1) (2) (3) (4) (5) 
I avoid conflict. (1) (2) (3) (4) (5) 
I like when other people 
challenge my opinion.  (1) (2) (3) (4) (5) 
It annoys me when I know 
someone else is upset with 
me but refuses to discuss it. 
(1) (2) (3) (4) (5) 
In a relationship, it is 
important for me to feel 
emotionally supported by my 
partner. 
(1) (2) (3) (4) (5) 
When in a relationship, I 
often need a lot of space. (1) (2) (3) (4) (5) 
Communication is very 
important to me in a 
relationship. 
(1) (2) (3) (4) (5) 
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Social Desirability Scale  
 
Listed below are a number of statements concerning personal attitudes and traits. Read 
each item and decide whether the statement is true or false as it pertains to you 
personally. It’s best to go with your first judgment and not spend too long mulling over 
any one question. Please circle ‘True’ or ‘False.’ 
 
Before voting I thoroughly investigate the qualifications of all the candidates. True    False 
I never hesitate to go out of my way to help someone in trouble. True    False 
It is sometimes hard for me to go on with my work if I am not encouraged. True    False 
I have never intensely disliked anyone. True    False 
On occasions I have had doubts about my ability to succeed in life. True    False 
I sometimes feel resentful when I don’t get my way. True    False 
I am always careful about my manner of dress. True    False 
My table manners at home are as good as when I eat out in a restaurant. True    False 
If I could get into a movie without paying and be sure I was not seen I would 
probably do it. 
True    False 
On a few occasions, I have given up something because I thought too little of my 
ability. 
True    False 
I like to gossip at times. True    False 
There have been times when I felt like rebelling against people in authority even 
though I knew they were right. 
True    False 
No matter who I’m talking to, I’m always a good listener. True    False 
I can remember “playing sick” to get out of something. True    False 
There have been occasions when I have taken advantage of someone. True    False 
I’m always willing to admit it when I make a mistake. True    False 
I always try to practice what I preach. True    False 
I don’t find it particularly difficult to get along with loudmouthed, obnoxious 
people. 
True    False 
I sometimes try to get even rather than forgive and forget. True    False 
When I don’t know something I don’t mind at all admitting it. True    False 
I am always courteous, even to people who are disagreeable. True    False 
At times I have really insisted on having things my own way. True    False 
There have been occasions when I felt like smashing things. True    False 
I would never think of letting someone else be punished for my wrong-doings. True    False 
I never resent being asked to return a favor. True    False 
I have never been irked when people expressed ideas very different from my 
own. 
True    False 
I never make a long trip without checking the safety of my car. True    False 
There have been times when I was quite jealous of the good fortune of others. True    False 
I have almost never felt the urge to tell someone off. True    False 
I am sometimes irritated by people who ask favors of me. True    False 
I have never felt that I was punished without cause. True    False 
I sometimes think when people have a misfortune they only got what they 
deserved. 
True    False 
I have never deliberately said something that hurt someone’s feelings. True    False 
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Using the following scale, please indicate the degree to which you agree or disagree with 
the following statements.  Write the number corresponding to your level of agreement or 
disagreement on the space following each statement.   
 
Strongly Disagree     Disagree                  Neither Agree             Agree        Strongly Agree  
       Nor Disagree 
           1              2           3    4             5 
 
At this point in my life, I am interested in dating.  _____ 
 
I would like the opportunity to get to know more members of the opposite sex. ____ 
 
I think that everyone has their own unique scent.  _____ 
I believe that humans can detect the pheromones, or scent, of others.  _____ 
I believe that a person’s scent influences attraction.  _____ 
I don’t think that a person’s scent is an important component in physical attraction. _____ 
If I met the right person, I would be interested in pursuing a romantic relationship        
with them. ____ 
 
There is much scientific evidence to show that scent influences attraction.  _____ 
In the past, I have noticed that a person’s scent has increased my attraction to that   
person .____ 
 
I have heard a lot about pheromones before this study.  ____ 
I believe that scent plays a role in the physical chemistry between two people.  _____ 
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The following statements assess your opinions regarding this study.  Using the following 
scale, please indicate the degree to which you agree or disagree with each statement.  
Write the number corresponding to your level of agreement or disagreement on the space 
following each statement.   
 
Strongly Disagree     Disagree                  Neither Agree             Agree        Strongly Agree  
       Nor Disagree 
           1              2           3    4             5 
In this study,……………..  
I think that I will have no difficulty in rating the pheromone samples.  ____ 
I hope that I notice differences among the different scents.  _____ 
I want to respond positively to the scent of my match.  _____ 
I am looking forward to rating the different scents.  _____ 
When I am rating the scents, I plan to give it my best effort.  _____ 
 
It really wouldn’t bother me if I didn’t notice any differences among the different     
scents. _____ 
 
I would be interested in participating in more research studies like this one.  _____ 
 
I would be disappointed if I didn’t notice differences among the scents.  _____ 
 
It really wouldn’t bother me if I didn’t find my match’s scent to be most pleasing.  _____ 
 
I am not very interested in this study.  _____  
 
I don’t think that I will notice differences among the different scents.  _____ 
I hope that I find the scent of my match to be most pleasing.  _____ 
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Scent Ratings 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Arousing
  
Un-arousing 
Unsexy          Sexy 
Unattractive Attractive Neutral 
Neutral 
Neutral 
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Lo Expectancy, Hi Motivation Prompt: 
 
1) As you read online, this study is examining attraction and dating: specifically, how 
pheromones influence these variables.  Have you heard about pheromones before? ……. 
Pheromones are chemicals secreted by all animals, including humans. Although some 
scientists claim pheromones play an important role in attraction, most research has not 
supported this claim.  It seems that human beings are not able to detect pheromones and 
that pheromones really don’t do much of anything in humans.  In most studies like this, 
most people aren’t able to smell the pheromone sample. Because of this, it does not 
appear that pheromones play any role in attraction.  Does it make sense to you how 
pheromones don’t appear to influence attraction? ……..  In this study, you will be 
evaluating the pheromone samples of members of the opposite sex who have 
submitted these samples to us throughout the course of the study.  Based on the 
results of the personality and values questionnaire you filled out, we have selected a 
compatible match from a member of the opposite sex.  We are interested in studying 
those individuals who are compatible on both physical and emotional dimensions. If 
you rate your match’s pheromone sample to be the most pleasing, you will have the 
opportunity to participate in the second stage of this study in which you and this 
other person will meet and we will perform further pheromone tests; this part 
would be optional.   
 
Lo Expectancy, Lo Motivation Prompt: 
2)  As you read online, this study is examining attraction and dating: specifically, how 
pheromones influence these variables.  Have you heard about pheromones before? …….  
Pheromones are chemicals secreted by all animals, including humans. Although some 
scientists claim pheromones play an important role in attraction, most research has not 
supported this claim.  It seems that human beings are not able to detect pheromones and 
that pheromones really don’t do much of anything in humans.  In most studies like this, 
most people aren’t able to smell the pheromone sample. Because of this, it does not 
appear that pheromones play any role in attraction.  Does it make sense to you how 
pheromones don’t appear to influence attraction? ……..  In this study, we want to 
examine this further.  You will be evaluating the pheromone samples of members of 
the opposite sex.  Based on the results of the personality and values questionnaire 
you filled out, we have selected a compatible match from a member of the opposite 
sex.  You will be evaluating their pheromone sample along with the samples from 
three randomly selected males/females.  We are interested to see if you rate your 
match’s sample as most pleasing.  The identities of these people will remain 
anonymous.   This study is for educational purposes only.   
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Hi Expectancy, Lo Motivation Prompt: 
3)  As you read online, this study is examining attraction and dating: specifically, how 
pheromones influence these variables.  Have you heard about pheromones before? ……. 
Pheromones are chemicals secreted by all animals, including humans. In studies like this 
one, most people are able to detect different pheromone scents and there is much 
research which suggests that pheromones are an important component of attraction.  
Moreover, research has found that those couples who have both physical chemistry, 
which has been linked to pheromones, and emotional and personality compatibility, have 
the most satisfying relationships.  Does it make sense to you how the scent of pheromones 
can increase your attraction to someone?.................. In this study, you will be 
evaluating the pheromone samples of members of the opposite sex who have 
submitted these samples to us throughout the course of the study.  Based on the 
results of the personality and values questionnaire you filled out, we have selected a 
compatible match from a member of the opposite sex.  You will be evaluating their 
pheromone sample along with the samples from three randomly selected 
males/females.  We are interested to see if you rate your match’s sample as most 
pleasing.  The identities of these people will remain anonymous.   This study is for 
educational purposes only.   
 
 
Hi Expectancy, Hi Motivation Prompt: 
4) As you read online, this study is examining attraction and dating: specifically, how 
pheromones influence these variables.  Have you heard about pheromones before? ……. 
Pheromones are chemicals secreted by all animals, including humans. In studies like this 
one, most people are able to detect different pheromone scents and there is much 
research which suggests that pheromones are an important component of attraction.  
Moreover, research has found that those couples who have both physical chemistry, 
which has been linked to pheromones, and emotional and personality compatibility, have 
the most satisfying relationships.  Does it make sense to you how the scent of pheromones 
can increase your attraction to someone?.................. In this study, you will be 
evaluating the pheromone samples of members of the opposite sex who have 
submitted these samples to us throughout the course of the study.  Based on the 
results of the personality and values questionnaire you filled out, we have selected a 
compatible match from a member of the opposite sex.  We are interested in studying 
those individuals who are compatible on both physical and emotional dimensions. If 
you rate your match’s pheromone sample to be the most pleasing, you will have the 
opportunity to participate in the second stage of this study in which you and this 
other person will meet and we will perform further pheromone tests; this part 
would be optional.   
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Pheromone Rating Task Prompt (for all 4 experimental groups): 
 
Here are four pheromone samples collected from males/females who have participated in 
this study at some point.  One of these samples is from a male/female who has been 
matched to you using the results of your personality and values quiz and three are random 
samples.  Rate each of the samples on the following dimensions (show the rating scales to 
the subjects).  You will need to introspect, or look inside yourself, to examine how you 
are feeling.  When you begin, place the mask over your nose and mouth; you do not 
actually have to put the mask on.  Please take as much or as little time as you need in 
smelling each sample; you can smell each as many times as you want.    Remember that 
you may not notice differences in the samples and that’s o.k. if you do not.  The 
important thing is that you are honest in your answers.  If you do not notice a scent, 
please mark ‘neutral’ on the rating scale (show them ‘neutral on the scale.)  Please tell 
me when you are done.   
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2006-2007  University Fellowship 
   Indiana University Purdue University Indianapolis  
 
2004   Outstanding Business Student of 2004 
   University of Wisconsin-Madison 
 
2003   Holts, Smith, and Yates Women in Finance Scholarship  
   University of Wisconsin-Madison 
 
 
CLINICAL EXPERIENCE 
 
2010   Psychology Intern, Behavioral Medicine, Southwest Consortium,  
Albuquerque, NM     
• Conducted neuropsychological, decisional capacity, organ 
transplant, and pre-surgical evaluations  
• Led groups for pain management, smoking cessation, 
mindfulness, and weight loss  
• Participated in weekly interdisciplinary treatment meetings   
• Provided psychotherapy for patients with acute and chronic 
medical illness  
 
2009   Practicum Student, Indiana University Hospital, Indianapolis, IN 
• Provided psychotherapy for adult clients with a wide range 
of psychological disorders and chronic medical illness 
• Conducted diagnostic interviews, prepared treatment plans, 
and wrote integrated reports 
 
2008 Practicum Student, Riley Hospital Pain Center; Riley Hospital 
Child and Adolescent Psychiatric Clinic, Indianapolis, IN 
• Provided biofeedback, relaxation training, and 
psychotherapy for pain management in a pain clinic  
• Provided cognitive-behavioral therapy for children with 
anxiety and depression  
 
2008   Practicum Student, Larue Carter Hospital, Indianapolis, IN 
• Co-facilitated psychoeducation and psychosocial 
rehabilitation groups in an inpatient psychiatric hospital 
• Provided individual psychotherapy  
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2007 Practicum Student, Indiana University Neuropsychological 
Center, Indianapolis, IN  
• Conducted full neuropsychological batteries for assessment 
of traumatic brain injury, dementia, organ transplant, and 
learning disability  
• Wrote integrated neuropsychological reports  
 
 
RESEARCH EXPERIENCE 
 
2006-2008   University Fellow, IUPUI Department of Psychology 
Conducted longitudinal research examining the role of 
expectancies, motivation and effort in student success and student 
ratings of course satisfaction. 
 
2005 Research Assistant, University of Wisconsin-Milwaukee 
Collected measures of self-reported stress, well-being, and EEG 
and blood pressure ratings for experimental research examining the 
physiological responses to betrayal and forgiveness.  
 
 
MASTER AND DISSERTATION PROJECTS 
 
2009-2011 Dissertation Title: The Role of Expectancy and Motivation in the 
Placebo Effect   
Examined the mechanisms through which placebo responses are 
produced in an experimental study of 165 students.  Found that 
motivation for the placebo substance to work led to greater 
attention to signs of change, which in turn, produced greater 
placebo response.  
 
2006-2008 Thesis Title: Do Expectations Explain the Effects of Expressive 
Writing?  
In an experimental study of 170 college students, examined the 
role of treatment expectancies in reducing illness, a treatment 
effect associated with the emotional disclosure of traumatic events.  
 
 
TEACHING EXPERIENCE 
 
2010-2011  Distance Learning Instructor, IUPUI Department of Psychology  
   Introduction to Psychology, online course, 2 semesters  
 
 
 
101 
 
 
2007-2010  Lecturer, IUPUI Department of Psychology 
   Social Psychology, 2 semesters  
   Introduction to Psychology, 4 semesters   
 
2007-2009  Preparing Future Faculty, IUPUI  
Attended seminars and workshops addressing pedagogical theory 
and skills. Received ongoing supervision and evaluation of 
teaching by a senior faculty member.   
 
2006   Teaching Assistant, IUPUI Department of Psychology 
   Abnormal Psychology, 1 semester  
   Drugs and Addiction, 1 semester  
   Social Psychology, 1 semester   
 
 
GUEST LECTURES 
 
2011   Motivation and Placebo 
   Research Symposium, Raymond Murphy VA, Albuquerque, NM  
 
2009   Mechanisms Involved in Placebo 
   Clinical Psychology Brown Bag, IUPUI 
 
 
PRESENTATIONS 
 
Aigner, C. & Svanum, S.  (2009).  The Influence of Student Motivation and 
Course Performance on Student Evaluations of Teaching.  Poster presented at the 
Association for Psychological Science Annual Conference, San Francisco, CA. 
 
Svanum, S. & Aigner, C. (2008).  Student grade success influences course 
satisfaction.  Poster presented at the Association for Psychological Science Annual 
Conference, Chicago, IL. 
 
 
PUBLICATIONS 
 
Svanum, S. & Aigner, C. (in press). The influence of course effort, mastery and 
performance goals, grade expectancies, and course grades on student ratings of course 
satisfaction. British Journal of Educational Psychology.  
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WORKSHOPS ATTENDED 
 
2010 Motivational Interviewing, two day training 
 Eric Levensky, Ph.D. 
 Albuquerque, NM 
 
2010 Gathering of Healers, four day retreat 
Training in indigenous healing practices with the goal of 
integrating these ideas into team building, conflict resolution, and 
clinical practice  
 Albuquerque, NM 
 
2010 Evidence-Based Practice, one day workshop 
 Barbara Walker, Ph.D. 
 Indianapolis, IN  
 
2008 Motivational Interviewing, two day training  
 John M. Wryobeck, Ph.D. 
 Indianapolis, IN 
 
 
PROFESSIONAL MEMBERSHIPS  
 
2010-2011 Society of Behavioral Medicine 
 Student Member  
 
2007-2009 Association for Psychological Science  
 Student Member  
 
 
